Publications for Kerstin Brismar

Article

1 Mohanty S, Kamolvit W, Zambrana S, Gonzales E, Tovi J, Brismar K, Ostenson CG, Brauner A. HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients. JOURNAL OF MOLECULAR MEDICINE-JMM 2022 100:1 101-113
2 Zheng X, Narayanan S, Xu C, Eliasson Angelstig S, Grünler J, Zhao A, Di Toro A, Bernardi L, Mazzone M, Carmeliet P, Del Sole M, Solaini G, Forsberg EA, Zhang A, Brismar K, Schiffer TA, Rajamand Ekberg N, Botusan IR, Palm F, Catrina SB. Repression of hypoxia-inducible factor-1 contributes to increased mitochondrial reactive oxygen species production in diabetes. eLife 2022 11:
3 Dallner G, Bentinger M, Hussain S, Sinha I, Yang JN, Schwank-Xu C, Zheng XW, Swiezewska E, Brismar K, Valladolid-Acebes I, Tekle M. Dehydro-Tocotrienol-beta Counteracts Oxidative-Stress-Induced Diabetes Complications in db/db Mice. ANTIOXIDANTS 2021 10:7
4 Rossen J, Larsson K, Hagströmer M, Yngve A, Brismar K, Ainsworth B, Åberg L, Johansson UB. Effects of a three-armed randomised controlled trial using self-monitoring of daily steps with and without counselling in prediabetes and type 2 diabetes-the Sophia Step Study. The international journal of behavioral nutrition and physical activity 2021 18:1 121-
5 Eklund E, Hellberg A, Berglund B, Brismar K, Hirschberg AL. IGF-I and IGFBP-1 in Relation to Body Composition and Physical Performance in Female Olympic Athletes. FRONTIERS IN ENDOCRINOLOGY 2021 12: 708421-
6 Schwank-Xu C, Forsberg E, Bentinger M, Zhao AL, Ansurudeen I, Dallner G, Catrina SB, Brismar K, Tekle M. L-Carnosine Stimulation of Coenzyme Q10 Biosynthesis Promotes Improved Mitochondrial Function and Decreases Hepatic Steatosis in Diabetic Conditions. ANTIOXIDANTS 2021 10:5
7 Rossen J, Hagströmer M, Yngve A, Brismar K, Ainsworth B, Johansson UB. Process evaluation of the Sophia Step Study- a primary care based three-armed randomized controlled trial using self-monitoring of steps with and without counseling in prediabetes and type 2 diabetes. BMC public health 2021 21:1 1191-
8 Özgümüş T, Sulaieva O, Jessen LE, Jain R, Falhammar H, Nyström T, Catrina SB, Jörneskog G, Groop L, Eliasson M, Eliasson B, Brismar K, Stokowy T, Nilsson PM, Lyssenko V. Reduced expression of OXPHOS and DNA damage genes is linked to protection from microvascular complications in long-term type 1 diabetes: the PROLONG study. Scientific reports 2021 11:1 20735-
9 Entrop JP, Kullberg S, Grunewald J, Eklund A, Brismar K, Arkema EV. Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids. ERJ open research 2021 7:2
10 Kong LH, Nilsson IAK, Brismar K, Gissler M, Lavebratt C. Associations of Different Types of Maternal Diabetes and Body Mass Index With Offspring Psychiatric Disorders. JAMA NETWORK OPEN 2020 3:2 e1920787-
11 Rossen J, Von Rosen P, Johansson UB, Brismar K, Hagstromer M. Associations of physical activity and sedentary behavior with cardiometabolic biomarkers in prediabetes and type 2 diabetes: a compositional data analysis. PHYSICIAN AND SPORTSMEDICINE 2020 48:2 222-228
12 Sandin A, Olofsson C, Stralfors A, Ekberg NR, Brismar K, Juntti-Berggren L, Eggertsen G. Human apolipoprotein CIII levels; evaluation of three assay methods. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION 2020 80:3 230-235
13 Keindl M, Fedotkina O, du Plessis E, Jain R, Bergum B, Jensen TM, Moller CL, Falhammar H, Nystrom T, Catrina SB, Jorneskog G, Groop L, Eliasson M, Eliasson B, Brismar K, Nilsson PM, Berg TJ, Appel S, Lyssenko V. Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms. FRONTIERS IN ENDOCRINOLOGY 2020 11: 575469-
14 Jain R, Özgümüş T, Jensen TM, du Plessis E, Keindl M, Møller CL, Falhammar H, Nyström T, Catrina SB, Jörneskog G, Jessen LE, Forsblom C, Haukka JK, Groop PH, Rossing P, Groop L, Eliasson M, Eliasson B, Brismar K, Al-Majdoub M, Nilsson PM, Taskinen MR, Ferrannini E, Spégel P, Berg TJ, Lyssenko V. Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes. Scientific reports 2020 10:1 11561-
15 Ahanian T, Curman P, Leong IUS, Brismar K, Bachar-Wikstrom E, Cederlof M, Wikstrom JD. Metabolic phenotype in Darier disease: a cross-sectional clinical study. DIABETOLOGY & METABOLIC SYNDROME 2020 12:1 12-
16 Ekberg NR, Falhammar H, Näslund E, Brismar K. Predictors of normalized HbA1c after gastric bypass surgery in subjects with abnormal glucose levels, a 2-year follow-up study. Scientific reports 2020 10:1 15127-
17 Alehagen U, Aaseth J, Alexander J, Brismar K, Larsson A. Selenium and Coenzyme Q10 Supplementation Improves Renal Function in Elderly Deficient in Selenium: Observational Results and Results from a Subgroup Analysis of a Prospective Randomised Double-Blind Placebo-Controlled Trial. NUTRIENTS 2020 12:12
18 Zhang X, Gu HF, Frystyk J, Efendic S, Brismar K, Thorell A. Analyses of IGFBP2 DNA methylation and mRNA expression in visceral and subcutaneous adipose tissues of obese subjects. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2019 45: 31-36
19 Smáradóttir MI, Catrina SB, Brismar K, Norhammar A, Gyberg V, Mellbin LG. Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohort. Diabetes & vascular disease research 2019 16:1 22-27
20 Paschen M, Moede T, Valladolid-Acebes I, Leibiger B, Moruzzi N, Jacob S, García-Prieto CF, Brismar K, Leibiger IB, Berggren PO. Diet-induced β-cell insulin resistance results in reversible loss of functional β-cell mass. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2019 33:1 204-218
21 Hirschberg AL, Tani E, Brismar K, Lundstrom E. Effects of drospirenone and norethisterone acetate combined with estradiol on mammographic density and proliferation of breast epithelial cells-A prospective randomized trial. MATURITAS 2019 126: 18-24
22 Salem RM, Todd JN, Sandholm N, Cole JB, Chen WM, Andrews D, Pezzolesi MG, McKeigue PM, Hiraki LT, Qiu C, Nair V, Di Liao C, Cao JJ, Valo E, Onengut-Gumuscu S, Smiles AM, McGurnaghan SJ, Haukka JK, Harjutsalo V, Brennan EP, van Zuydam N, Ahlqvist E, Doyle R, Ahluwalia TS, Lajer M, Hughes MF, Park J, Skupien J, Spiliopoulou A, Liu A, Menon R, Boustany-Kari CM, Kang HM, Nelson RG, Klein R, Klein BE, Lee KE, Gao X, Mauer M, Maestroni S, Caramori ML, de Boer IH, Miller RG, Guo J, Boright AP, Tregouet D, Gyorgy B, Snell-Bergeon JK, Maahs DM, Bull SB, Canty AJ, Palmer CNA, Stechemesser L, Paulweber B, Weitgasser R, Sokolovska J, Rovīte V, Pīrāgs V, Prakapiene E, Radzeviciene L, Verkauskiene R, Panduru NM, Groop LC, McCarthy MI, Gu HF, Möllsten A, Falhammar H, Brismar K, Martin F, Rossing P, Costacou T, Zerbini G, Marre M, Hadjadj S, McKnight AJ, Forsblom C, McKay G, Godson C, Maxwell AP, Kretzler M, Susztak K, Colhoun HM, Krolewski A, Paterson AD, Groop PH, Rich SS, Hirschhorn JN, Florez JC, SUMMIT Consortium DCCT/EDIC Research Group GENIE Consortium. Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen. Journal of the American Society of Nephrology : JASN 2019 30:10 2000-2016
23 Hage C, Bjerre M, Frystyk J, Gu HF, Brismar K, Donal E, Daubert JC, Linde C, Lund LH. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction. The American journal of cardiology 2018 121:12 1558-1566
24 Botusan IR, Zheng X, Narayanan S, Grünler J, Sunkari VG, Calissendorff FS, Ansurudeen I, Illies C, Svensson J, Jansson JO, Ohlsson C, Brismar K, Catrina SB. Deficiency of liver-derived insulin-like growth factor-I (IGF-I) does not interfere with the skin wound healing rate. PloS one 2018 13:3 e0193084-
25 Ritsinger V, Brismar K, Mellbin L, Näsman P, Rydén L, Söderberg S, Norhammar A. Elevated levels of insulin-like growth factor-binding protein 1 predict outcome after acute myocardial infarction: A long-term follow-up of the glucose tolerance in patients with acute myocardial infarction (GAMI) cohort. Diabetes & vascular disease research 2018 15:5 387-395
26 Yang J, Zheng X, Mahdi A, Zhou Z, Tratsiakovich Y, Jiao T, Kiss A, Kövamees O, Alvarsson M, Catrina SB, Lundberg JO, Brismar K, Pernow J. Red Blood Cells in Type 2 Diabetes Impair Cardiac Post-Ischemic Recovery Through an Arginase-Dependent Modulation of Nitric Oxide Synthase and Reactive Oxygen Species. JACC. Basic to translational science 2018 3:4 450-463
27 Daraio T, Valladolid-Acebes I, Brismar K, Bark C. SNAP-25a and SNAP-25b differently mediate interactions with Munc18-1 and Gβγ subunits. Neuroscience letters 2018 674: 75-80
28 Olofsson C, Discacciati A, Åkesson A, Orsini N, Brismar K, Wolk A. Changes in fruit, vegetable and juice consumption after the diagnosis of type 2 diabetes: a prospective study in men. The British journal of nutrition 2017 117:5 712-719
29 Ritsinger V, Brismar K, Malmberg K, Mellbin L, Näsman P, Rydén L, Söderberg S, Tenerz Å, Norhammar A. Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort. Diabetes & vascular disease research 2017 14:2 77-87
30 Faxén UL, Hage C, Benson L, Zabarovskaja S, Andreasson A, Donal E, Daubert JC, Linde C, Brismar K, Lund LH. HFpEF and HFrEF Display Different Phenotypes as Assessed by IGF-1 and IGFBP-1. Journal of cardiac failure 2017 23:4 293-303
31 Faxén UL, Hage C, Andreasson A, Donal E, Daubert JC, Linde C, Brismar K, Lund LH. HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin. International journal of cardiology 2017 228: 709-716
32 Stilling F, Wallenius S, Michaëlsson K, Dalgård C, Brismar K, Wolk A. High insulin-like growth factor-binding protein-1 (IGFBP-1) is associated with low relative muscle mass in older women. Metabolism: clinical and experimental 2017 73: 36-42
33 Hagström H, Stål P, Hultcrantz R, Brismar K, Ansurudeen I. IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study. Scandinavian journal of gastroenterology 2017 52:12 1427-1434
34 Alehagen U, Johansson P, Aaseth J, Alexander J, Brismar K. Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. PloS one 2017 12:6 e0178614-
35 Xu C, Bentinger M, Savu O, Moshfegh A, Sunkari V, Dallner G, Swiezewska E, Catrina SB, Brismar K, Tekle M. Mono-epoxy-tocotrienol-α enhances wound healing in diabetic mice and stimulates in vitro angiogenesis and cell migration. Journal of diabetes and its complications 2017 31:1 4-12
36 Levitsky A, Brismar K, Hafström I, Hambardzumyan K, Lourdudoss C, van Vollenhoven RF, Saevarsdottir S. Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial. RMD open 2017 3:2 e000458-
37 Rossen J, Buman MP, Johansson UB, Yngve A, Ainsworth B, Brismar K, Hagströmer M. Reallocating bouted sedentary time to non-bouted sedentary time, light activity and moderate-vigorous physical activity in adults with prediabetes and type 2 diabetes. PloS one 2017 12:7 e0181053-
38 Daraio T, Bombek LK, Gosak M, Valladolid-Acebes I, Klemen MS, Refai E, Berggren PO, Brismar K, Rupnik MS, Bark C. SNAP-25b-deficiency increases insulin secretion and changes spatiotemporal profile of Ca2+oscillations in β cell networks. Scientific reports 2017 7:1 7744-
39 Bennet L, Stenkula K, Cushman SW, Brismar K. BMI and waist circumference cut-offs for corresponding levels of insulin sensitivity in a Middle Eastern immigrant versus a native Swedish population - the MEDIM population based study. BMC public health 2016 16:1 1242-
40 Arnetz L, Hage C, Brismar K, Catrina SB, Norhammar A, Lundman P, Wallander M, Ryden L, Mellbin L. Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction study. Diabetes & vascular disease research 2016 13:4 307-11
41 Ekström EC, Lindström E, Raqib R, El Arifeen S, Basu S, Brismar K, Selling K, Persson LÅ. Effects of prenatal micronutrient and early food supplementation on metabolic status of the offspring at 4.5 years of age. The MINIMat randomized trial in rural Bangladesh. International journal of epidemiology 2016 45:5 1656-1667
42 Bang P, Thorell A, Carlsson-Skwirut C, Ljungqvist O, Brismar K, Nygren J. Free dissociable IGF-I: Association with changes in IGFBP-3 proteolysis and insulin sensitivity after surgery. Clinical nutrition (Edinburgh, Scotland) 2016 35:2 408-413
43 Bergen K, Brismar K, Tehrani S. High-dose atorvastatin is associated with lower IGF-1 levels in patients with type 1 diabetes. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2016 29: 78-82
44 Lu J, Liu KC, Schulz N, Karampelias C, Charbord J, Hilding A, Rautio L, Bertolino P, Östenson CG, Brismar K, Andersson O. IGFBP1 increases β-cell regeneration by promoting α- to β-cell transdifferentiation. The EMBO journal 2016 35:18 2026-44
45 Koubaa S, Hällström T, Brismar K, Hellström PM, Hirschberg AL. Biomarkers of nutrition and stress in pregnant women with a history of eating disorders in relation to head circumference and neurocognitive function of the offspring. BMC pregnancy and childbirth 2015 15: 318-
46 Forsberg EA, Botusan IR, Wang J, Peters V, Ansurudeen I, Brismar K, Catrina SB. Carnosine decreases IGFBP1 production in db/db mice through suppression of HIF-1. The Journal of endocrinology 2015 225:3 159-67
47 Forsberg E, Xu C, Grünler J, Frostegård J, Tekle M, Brismar K, Kärvestedt L. Coenzyme Q10 and oxidative stress, the association with peripheral sensory neuropathy and cardiovascular disease in type 2 diabetes mellitus. Journal of diabetes and its complications 2015 29:8 1152-8
48 Brandt K, Grünler J, Brismar K, Wang J. Effects of IGFBP-1 and IGFBP-2 and their fragments on migration and IGF-induced proliferation of human dermal fibroblasts. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2015 25:1 34-40
49 Onengut-Gumuscu S, Chen WM, Burren O, Cooper NJ, Quinlan AR, Mychaleckyj JC, Farber E, Bonnie JK, Szpak M, Schofield E, Achuthan P, Guo H, Fortune MD, Stevens H, Walker NM, Ward LD, Kundaje A, Kellis M, Daly MJ, Barrett JC, Cooper JD, Deloukas P, Todd JA, Wallace C, Concannon P, Rich SS, Type 1 Diabetes Genetics Consortium. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nature genetics 2015 47:4 381-6
50 Arnetz L, Rajamand Ekberg N, Brismar K, Alvarsson M. Gender difference in adrenal sensitivity to ACTH is abolished in type 2 diabetes. Endocrine connections 2015 4:2 92-9
51 Abu Seman N, Anderstam B, Wan Mohamud WN, Östenson CG, Brismar K, Gu HF. Genetic, epigenetic and protein analyses of intercellular adhesion molecule 1 in Malaysian subjects with type 2 diabetes and diabetic nephropathy. Journal of diabetes and its complications 2015 29:8 1234-9
52 Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, Powell C, Vedantam S, Buchkovich ML, Yang J, Croteau-Chonka DC, Esko T, Fall T, Ferreira T, Gustafsson S, Kutalik Z, Luan J, Mägi R, Randall JC, Winkler TW, Wood AR, Workalemahu T, Faul JD, Smith JA, Zhao JH, Zhao W, Chen J, Fehrmann R, Hedman ÅK, Karjalainen J, Schmidt EM, Absher D, Amin N, Anderson D, Beekman M, Bolton JL, Bragg-Gresham JL, Buyske S, Demirkan A, Deng G, Ehret GB, Feenstra B, Feitosa MF, Fischer K, Goel A, Gong J, Jackson AU, Kanoni S, Kleber ME, Kristiansson K, Lim U, Lotay V, Mangino M, Leach IM, Medina-Gomez C, Medland SE, Nalls MA, Palmer CD, Pasko D, Pechlivanis S, Peters MJ, Prokopenko I, Shungin D, Stančáková A, Strawbridge RJ, Sung YJ, Tanaka T, Teumer A, Trompet S, van der Laan SW, van Setten J, Van Vliet-Ostaptchouk JV, Wang Z, Yengo L, Zhang W, Isaacs A, Albrecht E, Ärnlöv J, Arscott GM, Attwood AP, Bandinelli S, Barrett A, Bas IN, Bellis C, Bennett AJ, Berne C, Blagieva R, Blüher M, Böhringer S, Bonnycastle LL, Böttcher Y, Boyd HA, Bruinenberg M, Caspersen IH, Chen YI, Clarke R, Daw EW, de Craen AJM, Delgado G, Dimitriou M, Doney ASF, Eklund N, Estrada K, Eury E, Folkersen L, Fraser RM, Garcia ME, Geller F, Giedraitis V, Gigante B, Go AS, Golay A, Goodall AH, Gordon SD, Gorski M, Grabe HJ, Grallert H, Grammer TB, Gräßler J, Grönberg H, Groves CJ, Gusto G, Haessler J, Hall P, Haller T, Hallmans G, Hartman CA, Hassinen M, Hayward C, Heard-Costa NL, Helmer Q, Hengstenberg C, Holmen O, Hottenga JJ, James AL, Jeff JM, Johansson Å, Jolley J, Juliusdottir T, Kinnunen L, Koenig W, Koskenvuo M, Kratzer W, Laitinen J, Lamina C, Leander K, Lee NR, Lichtner P, Lind L, Lindström J, Lo KS, Lobbens S, Lorbeer R, Lu Y, Mach F, Magnusson PKE, Mahajan A, McArdle WL, McLachlan S, Menni C, Merger S, Mihailov E, Milani L, Moayyeri A, Monda KL, Morken MA, Mulas A, Müller G, Müller-Nurasyid M, Musk AW, Nagaraja R, Nöthen MM, Nolte IM, Pilz S, Rayner NW, Renstrom F, Rettig R, Ried JS, Ripke S, Robertson NR, Rose LM, Sanna S, Scharnagl H, Scholtens S, Schumacher FR, Scott WR, Seufferlein T, Shi J, Smith AV, Smolonska J, Stanton AV, Steinthorsdottir V, Stirrups K, Stringham HM, Sundström J, Swertz MA, Swift AJ, Syvänen AC, Tan ST, Tayo BO, Thorand B, Thorleifsson G, Tyrer JP, Uh HW, Vandenput L, Verhulst FC, Vermeulen SH, Verweij N, Vonk JM, Waite LL, Warren HR, Waterworth D, Weedon MN, Wilkens LR, Willenborg C, Wilsgaard T, Wojczynski MK, Wong A, Wright AF, Zhang Q, Brennan EP, Choi M, Dastani Z, Drong AW, Eriksson P, Franco-Cereceda A, Gådin JR, Gharavi AG, Goddard ME, Handsaker RE, Huang J, Karpe F, Kathiresan S, Keildson S, Kiryluk K, Kubo M, Lee JY, Liang L, Lifton RP, Ma B, McCarroll SA, McKnight AJ, Min JL, Moffatt MF, Montgomery GW, Murabito JM, Nicholson G, Nyholt DR, Okada Y, Perry JRB, Dorajoo R, Reinmaa E, Salem RM, Sandholm N, Scott RA, Stolk L, Takahashi A, Tanaka T, van 't Hooft FM, Vinkhuyzen AAE, Westra HJ, Zheng W, Zondervan KT, Heath AC, Arveiler D, Bakker SJL, Beilby J, Bergman RN, Blangero J, Bovet P, Campbell H, Caulfield MJ, Cesana G, Chakravarti A, Chasman DI, Chines PS, Collins FS, Crawford DC, Cupples LA, Cusi D, Danesh J, de Faire U, den Ruijter HM, Dominiczak AF, Erbel R, Erdmann J, Eriksson JG, Farrall M, Felix SB, Ferrannini E, Ferrières J, Ford I, Forouhi NG, Forrester T, Franco OH, Gansevoort RT, Gejman PV, Gieger C, Gottesman O, Gudnason V, Gyllensten U, Hall AS, Harris TB, Hattersley AT, Hicks AA, Hindorff LA, Hingorani AD, Hofman A, Homuth G, Hovingh GK, Humphries SE, Hunt SC, Hyppönen E, Illig T, Jacobs KB, Jarvelin MR, Jöckel KH, Johansen B, Jousilahti P, Jukema JW, Jula AM, Kaprio J, Kastelein JJP, Keinanen-Kiukaanniemi SM, Kiemeney LA, Knekt P, Kooner JS, Kooperberg C, Kovacs P, Kraja AT, Kumari M, Kuusisto J, Lakka TA, Langenberg C, Marchand LL, Lehtimäki T, Lyssenko V, Männistö S, Marette A, Matise TC, McKenzie CA, McKnight B, Moll FL, Morris AD, Morris AP, Murray JC, Nelis M, Ohlsson C, Oldehinkel AJ, Ong KK, Madden PAF, Pasterkamp G, Peden JF, Peters A, Postma DS, Pramstaller PP, Price JF, Qi L, Raitakari OT, Rankinen T, Rao DC, Rice TK, Ridker PM, Rioux JD, Ritchie MD, Rudan I, Salomaa V, Samani NJ, Saramies J, Sarzynski MA, Schunkert H, Schwarz PEH, Sever P, Shuldiner AR, Sinisalo J, Stolk RP, Strauch K, Tönjes A, Trégouët DA, Tremblay A, Tremoli E, Virtamo J, Vohl MC, Völker U, Waeber G, Willemsen G, Witteman JC, Zillikens MC, Adair LS, Amouyel P, Asselbergs FW, Assimes TL, Bochud M, Boehm BO, Boerwinkle E, Bornstein SR, Bottinger EP, Bouchard C, Cauchi S, Chambers JC, Chanock SJ, Cooper RS, de Bakker PIW, Dedoussis G, Ferrucci L, Franks PW, Froguel P, Groop LC, Haiman CA, Hamsten A, Hui J, Hunter DJ, Hveem K, Kaplan RC, Kivimaki M, Kuh D, Laakso M, Liu Y, Martin NG, März W, Melbye M, Metspalu A, Moebus S, Munroe PB, Njølstad I, Oostra BA, Palmer CNA, Pedersen NL, Perola M, Pérusse L, Peters U, Power C, Quertermous T, Rauramaa R, Rivadeneira F, Saaristo TE, Saleheen D, Sattar N, Schadt EE, Schlessinger D, Slagboom PE, Snieder H, Spector TD, Thorsteinsdottir U, Stumvoll M, Tuomilehto J, Uitterlinden AG, Uusitupa M, van der Harst P, Walker M, Wallaschofski H, Wareham NJ, Watkins H, Weir DR, Wichmann HE, Wilson JF, Zanen P, Borecki IB, Deloukas P, Fox CS, Heid IM, O'Connell JR, Strachan DP, Stefansson K, van Duijn CM, Abecasis GR, Franke L, Frayling TM, McCarthy MI, Visscher PM, Scherag A, Willer CJ, Boehnke M, Mohlke KL, Lindgren CM, Beckmann JS, Barroso I, North KE, Ingelsson E, Hirschhorn JN, Loos RJF, Speliotes EK, CARDIOGRAMplusC4D Consortium, CKDGen Consortium, GLGC, ICBP, MAGIC Investigators, MuTHER Consortium, MIGen Consortium, AGEN-BMI Working Group, ADIPOGen Consortium, LifeLines Cohort Study, PAGE Consortium, ReproGen Consortium, GENIE Consortium, International Endogene Consortium. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015 518:7538 197-206
53 Brismar TB, Shams S, Berinder K, Berlin M, Udden J, Brismar K, Ringertz HG. GLUCOCORTICOIDS AND SARCOIDOSIS: A LONGITUDINAL STUDY ON THE EFFECTS ON CORTICAL AND TRABECULAR BONE. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES 2015 32:1 63-9
54 Montano SJ, Grünler J, Nair D, Tekle M, Fernandes AP, Hua X, Holmgren A, Brismar K, Ungerstedt JS. Glutaredoxin mediated redox effects of coenzyme Q10 treatment in type 1 and type 2 diabetes patients. BBA clinical 2015 4: 14-20
55 Sunkari VG, Lind F, Botusan IR, Kashif A, Liu ZJ, Ylä-Herttuala S, Brismar K, Velazquez O, Catrina SB. Hyperbaric oxygen therapy activates hypoxia-inducible factor 1 (HIF-1), which contributes to improved wound healing in diabetic mice. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2015 23:1 98-103
56 Arnetz L, Hage C, Ekberg NR, Alvarsson M, Brismar K, Norhammar A, Mellbin L. Improved glycemic control due to sitagliptin is not related to cortisol or the surrogate marker IGFBP-1 for hepatic insulin sensitivity. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2015 25:6 298-303
57 Seman NA, Mohamud WN, Östenson CG, Brismar K, Gu HF. Increased DNA methylation of the SLC30A8 gene promoter is associated with type 2 diabetes in a Malay population. Clinical epigenetics 2015 7: 30-
58 Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Mägi R, Strawbridge RJ, Pers TH, Fischer K, Justice AE, Workalemahu T, Wu JMW, Buchkovich ML, Heard-Costa NL, Roman TS, Drong AW, Song C, Gustafsson S, Day FR, Esko T, Fall T, Kutalik Z, Luan J, Randall JC, Scherag A, Vedantam S, Wood AR, Chen J, Fehrmann R, Karjalainen J, Kahali B, Liu CT, Schmidt EM, Absher D, Amin N, Anderson D, Beekman M, Bragg-Gresham JL, Buyske S, Demirkan A, Ehret GB, Feitosa MF, Goel A, Jackson AU, Johnson T, Kleber ME, Kristiansson K, Mangino M, Leach IM, Medina-Gomez C, Palmer CD, Pasko D, Pechlivanis S, Peters MJ, Prokopenko I, Stančáková A, Sung YJ, Tanaka T, Teumer A, Van Vliet-Ostaptchouk JV, Yengo L, Zhang W, Albrecht E, Ärnlöv J, Arscott GM, Bandinelli S, Barrett A, Bellis C, Bennett AJ, Berne C, Blüher M, Böhringer S, Bonnet F, Böttcher Y, Bruinenberg M, Carba DB, Caspersen IH, Clarke R, Daw EW, Deelen J, Deelman E, Delgado G, Doney AS, Eklund N, Erdos MR, Estrada K, Eury E, Friedrich N, Garcia ME, Giedraitis V, Gigante B, Go AS, Golay A, Grallert H, Grammer TB, Gräßler J, Grewal J, Groves CJ, Haller T, Hallmans G, Hartman CA, Hassinen M, Hayward C, Heikkilä K, Herzig KH, Helmer Q, Hillege HL, Holmen O, Hunt SC, Isaacs A, Ittermann T, James AL, Johansson I, Juliusdottir T, Kalafati IP, Kinnunen L, Koenig W, Kooner IK, Kratzer W, Lamina C, Leander K, Lee NR, Lichtner P, Lind L, Lindström J, Lobbens S, Lorentzon M, Mach F, Magnusson PK, Mahajan A, McArdle WL, Menni C, Merger S, Mihailov E, Milani L, Mills R, Moayyeri A, Monda KL, Mooijaart SP, Mühleisen TW, Mulas A, Müller G, Müller-Nurasyid M, Nagaraja R, Nalls MA, Narisu N, Glorioso N, Nolte IM, Olden M, Rayner NW, Renstrom F, Ried JS, Robertson NR, Rose LM, Sanna S, Scharnagl H, Scholtens S, Sennblad B, Seufferlein T, Sitlani CM, Smith AV, Stirrups K, Stringham HM, Sundström J, Swertz MA, Swift AJ, Syvänen AC, Tayo BO, Thorand B, Thorleifsson G, Tomaschitz A, Troffa C, van Oort FV, Verweij N, Vonk JM, Waite LL, Wennauer R, Wilsgaard T, Wojczynski MK, Wong A, Zhang Q, Zhao JH, Brennan EP, Choi M, Eriksson P, Folkersen L, Franco-Cereceda A, Gharavi AG, Hedman ÅK, Hivert MF, Huang J, Kanoni S, Karpe F, Keildson S, Kiryluk K, Liang L, Lifton RP, Ma B, McKnight AJ, McPherson R, Metspalu A, Min JL, Moffatt MF, Montgomery GW, Murabito JM, Nicholson G, Nyholt DR, Olsson C, Perry JR, Reinmaa E, Salem RM, Sandholm N, Schadt EE, Scott RA, Stolk L, Vallejo EE, Westra HJ, Zondervan KT, Amouyel P, Arveiler D, Bakker SJ, Beilby J, Bergman RN, Blangero J, Brown MJ, Burnier M, Campbell H, Chakravarti A, Chines PS, Claudi-Boehm S, Collins FS, Crawford DC, Danesh J, de Faire U, de Geus EJ, Dörr M, Erbel R, Eriksson JG, Farrall M, Ferrannini E, Ferrières J, Forouhi NG, Forrester T, Franco OH, Gansevoort RT, Gieger C, Gudnason V, Haiman CA, Harris TB, Hattersley AT, Heliövaara M, Hicks AA, Hingorani AD, Hoffmann W, Hofman A, Homuth G, Humphries SE, Hyppönen E, Illig T, Jarvelin MR, Johansen B, Jousilahti P, Jula AM, Kaprio J, Kee F, Keinanen-Kiukaanniemi SM, Kooner JS, Kooperberg C, Kovacs P, Kraja AT, Kumari M, Kuulasmaa K, Kuusisto J, Lakka TA, Langenberg C, Le Marchand L, Lehtimäki T, Lyssenko V, Männistö S, Marette A, Matise TC, McKenzie CA, McKnight B, Musk AW, Möhlenkamp S, Morris AD, Nelis M, Ohlsson C, Oldehinkel AJ, Ong KK, Palmer LJ, Penninx BW, Peters A, Pramstaller PP, Raitakari OT, Rankinen T, Rao DC, Rice TK, Ridker PM, Ritchie MD, Rudan I, Salomaa V, Samani NJ, Saramies J, Sarzynski MA, Schwarz PE, Shuldiner AR, Staessen JA, Steinthorsdottir V, Stolk RP, Strauch K, Tönjes A, Tremblay A, Tremoli E, Vohl MC, Völker U, Vollenweider P, Wilson JF, Witteman JC, Adair LS, Bochud M, Boehm BO, Bornstein SR, Bouchard C, Cauchi S, Caulfield MJ, Chambers JC, Chasman DI, Cooper RS, Dedoussis G, Ferrucci L, Froguel P, Grabe HJ, Hamsten A, Hui J, Hveem K, Jöckel KH, Kivimaki M, Kuh D, Laakso M, Liu Y, März W, Munroe PB, Njølstad I, Oostra BA, Palmer CN, Pedersen NL, Perola M, Pérusse L, Peters U, Power C, Quertermous T, Rauramaa R, Rivadeneira F, Saaristo TE, Saleheen D, Sinisalo J, Slagboom PE, Snieder H, Spector TD, Stefansson K, Stumvoll M, Tuomilehto J, Uitterlinden AG, Uusitupa M, van der Harst P, Veronesi G, Walker M, Wareham NJ, Watkins H, Wichmann HE, Abecasis GR, Assimes TL, Berndt SI, Boehnke M, Borecki IB, Deloukas P, Franke L, Frayling TM, Groop LC, Hunter DJ, Kaplan RC, O'Connell JR, Qi L, Schlessinger D, Strachan DP, Thorsteinsdottir U, van Duijn CM, Willer CJ, Visscher PM, Yang J, Hirschhorn JN, Zillikens MC, McCarthy MI, Speliotes EK, North KE, Fox CS, Barroso I, Franks PW, Ingelsson E, Heid IM, Loos RJ, Cupples LA, Morris AP, Lindgren CM, Mohlke KL, CKDGen Consortium, ReproGen Consortium, ADIPOGen Consortium, CARDIOGRAMplusC4D Consortium, PAGE Consortium, MuTHER Consortium, MAGIC Investigators, LifeLines Cohort Study, International Endogene Consortium, ICBP, GLGC, GENIE Consortium, GEFOS Consortium. New genetic loci link adipose and insulin biology to body fat distribution. Nature 2015 518:7538 187-196
59 Rossen J, Yngve A, Hagströmer M, Brismar K, Ainsworth BE, Iskull C, Möller P, Johansson UB. Physical activity promotion in the primary care setting in pre- and type 2 diabetes - the Sophia step study, an RCT. BMC public health 2015 15: 647-
60 Valladolid-Acebes I, Daraio T, Brismar K, Harkany T, Ögren SO, Hökfelt TG, Bark C. Replacing SNAP-25b with SNAP-25a expression results in metabolic disease. Proceedings of the National Academy of Sciences of the United States of America 2015 112:31 E4326-35
61 Malmstedt J, Kärvestedt L, Swedenborg J, Brismar K. The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study. Cardiovascular diabetology 2015 14: 93-
62 Bentinger M, Kania M, Danikiewicz W, Kaczorowska E, Wojcik J, Brismar K, Dallner G, Chojnacki T, Swiezewska E, Tekle M. Effects of various squalene epoxides on coenzyme Q and cholesterol synthesis. Biochimica et biophysica acta 2014 1841:7 977-86
63 Gu T, Falhammar H, Gu HF, Brismar K. Epigenetic analyses of the insulin-like growth factor binding protein 1 gene in type 1 diabetes and diabetic nephropathy. Clinical epigenetics 2014 6:1 10-
64 Vasan SK, Karpe F, Gu HF, Brismar K, Fall CH, Ingelsson E, Fall T. FTO genetic variants and risk of obesity and type 2 diabetes: a meta-analysis of 28,394 Indians. Obesity (Silver Spring, Md.) 2014 22:3 964-70
65 Abu Seman N, He B, Ojala JRM, Mohamud WNW, Ostenson CG, Brismar K, Gu HF. Genetic and Biological Effects of Sodium-Chloride Cotransporter (SLC12A3) in Diabetic Nephropathy. AMERICAN JOURNAL OF NEPHROLOGY 2014 40:5 408-16
66 Almgren M, Atkinson RL, Hilding A, He J, Brismar K, Schalling M, Ostenson CG, Lavebratt C. Human adenovirus-36 is uncommon in type 2 diabetes and is associated with increased insulin sensitivity in adults in Sweden. Annals of medicine 2014 46:7 539-46
67 Brauner H, Lüthje P, Grünler J, Ekberg NR, Dallner G, Brismar K, Brauner A. Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activity. Clinical and experimental immunology 2014 177:2 478-82
68 Du Y, Zhang H, Montano S, Hegestam J, Ekberg NR, Holmgren A, Brismar K, Ungerstedt JS. Plasma glutaredoxin activity in healthy subjects and patients with abnormal glucose levels or overt type 2 diabetes. Acta diabetologica 2014 51:2 225-32
69 Moruzzi N, Del Sole M, Fato R, Gerdes JM, Berggren PO, Bergamini C, Brismar K. Short and prolonged exposure to hyperglycaemia in human fibroblasts and endothelial cells: metabolic and osmotic effects. The international journal of biochemistry & cell biology 2014 53: 66-76
70 Marinou K, Hodson L, Vasan SK, Fielding BA, Banerjee R, Brismar K, Koutsilieris M, Clark A, Neville MJ, Karpe F. Structural and Functional Properties of Deep Abdominal Subcutaneous Adipose Tissue Explain Its Association With Insulin Resistance and Cardiovascular Risk in Men. DIABETES CARE 2014 37:3 821-9
71 Hage C, Brismar K, Lundman P, Norhammar A, Ryden L, Mellbin L. The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations: A report from the BEGAMI study. DIABETES & VASCULAR DISEASE RESEARCH 2014 11:4 290-293
72 Halldin M, Brismar K, Fahlstadius P, Vikström M, de Faire U, Hellénius ML. The metabolic syndrome and ECG detected left ventricular hypertrophy--influences from IGF-1 and IGF-binding protein-1. PloS one 2014 9:12 e108872-
73 Vasan SK, Fall T, Job V, Gu HF, Ingelsson E, Brismar K, Karpe F, Thomas N. A common variant in the FTO locus is associated with waist-hip ratio in Indian adolescents. Pediatric obesity 2013 8:3 e45-9
74 Hagmar M, Berglund B, Brismar K, Hirschberg AL. Body composition and endocrine profile of male Olympic athletes striving for leanness. Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine 2013 23:3 197-201
75 Falhammar H, Filipsson Nyström H, Wedell A, Brismar K, Thorén M. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia. European journal of endocrinology 2013 168:3 331-41
76 Oguz A, Benroubi M, Brismar K, Melo P, Morar C, Cleall SP, Giaconia J, Schmitt H. Clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes in five countries: results from the TREAT study. CURRENT MEDICAL RESEARCH AND OPINION 2013 29:8 911-20
77 Shi TJ, Zhang MD, Zeberg H, Nilsson J, Grünler J, Liu SX, Xiang Q, Persson J, Fried KJ, Catrina SB, Watanabe M, Arhem P, Brismar K, Hökfelt TG. Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model. Proceedings of the National Academy of Sciences of the United States of America 2013 110:2 690-5
78 Theuri G, Dallner G, Brismar K, Tekle M. Effects of lifestyle on plasma levels of the IGF system and the antioxidants coenzyme Q10 and vitamin E in Kenyan rural and urban populations. GROWTH HORMONE & IGF RESEARCH 2013 23:3 68-75
79 Jung C, Rafnsson A, Brismar K, Pernow J. Endothelial progenitor cells in relation to endothelin-1 and endothelin receptor blockade: a randomized, controlled trial. International journal of cardiology 2013 168:2 1017-22
80 Gu HF, Gu TW, Hilding A, Zhu YM, Karvestedt L, Ostenson CG, Lai MD, Kutsukake M, Frystyk J, Tamura K, Brismar K. Evaluation of IGFBP-7 DNA methylation changes and serum protein variation in Swedish subjects with and without type 2 diabetes. CLINICAL EPIGENETICS 2013 5: 20-
81 Brismar K, Benroubi M, Nicolay C, Schmitt H, Giaconia J, Reaney M. Evaluation of insulin initiation on resource utilization and direct costs of treatment over 12 months in patients with type 2 diabetes in Europe: results from INSTIGATE and TREAT observational studies. Journal of medical economics 2013 16:8 1022-35
82 Abu Seman N, Witasp A, Wan Mohamud WN, Anderstam B, Brismar K, Stenvinkel P, Gu HF. Evaluation of the association of plasma pentraxin 3 levels with type 2 diabetes and diabetic nephropathy in a Malay population. Journal of diabetes research 2013 2013: 298019-
83 Gu HF, Zheng X, Abu Seman N, Gu T, Botusan IR, Sunkari VG, Lokman EF, Brismar K, Catrina SB. Impact of the hypoxia-inducible factor-1 α (HIF1A) Pro582Ser polymorphism on diabetes nephropathy. Diabetes care 2013 36:2 415-21
84 Arnetz L, Rajamand Ekberg N, Höybye C, Brismar K, Alvarsson M. Improved Insulin Sensitivity during Pioglitazone Treatment Is Associated with Changes in IGF-I and Cortisol Secretion in Type 2 Diabetes and Impaired Glucose Tolerance. ISRN endocrinology 2013 2013: 148497-
85 Gu T, Gu HF, Hilding A, Sjöholm LK, Ostenson CG, Ekström TJ, Brismar K. Increased DNA methylation levels of the insulin-like growth factor binding protein 1 gene are associated with type 2 diabetes in Swedish men. Clinical epigenetics 2013 5:1 21-
86 Norenstedt S, Pernow Y, Brismar K, Sääf M, Ekip A, Granath F, Zedenius J, Nilsson IL. Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind study. European journal of endocrinology 2013 169:6 795-804
87 Venskutonyte L, Brismar K, Rydén-Bergsten T, Rydén L, Kjellström B. Satisfaction with glucose-lowering treatment and well-being in patients with type 2 diabetes and myocardial infarction: a DIGAMI2 QoL sub-study. Diabetes & vascular disease research 2013 10:3 263-9
88 Venskutonyte L, Brismar K, Öhrvik J, Rydén L, Kjellström B. Self-rated health predicts outcome in patients with type 2 diabetes and myocardial infarction: a DIGAMI 2 quality of life sub-study. Diabetes & vascular disease research 2013 10:4 361-7
89 Hage C, Brismar K, Efendic S, Lundman P, Rydén L, Mellbin L. Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities--the BEGAMI study. Journal of internal medicine 2013 273:4 410-21
90 Zheng X, Zheng X, Wang X, Ma Z, Sunkari VG, Botusan I, Takeda T, Bjorklund A, Inoue M, Catrina SB, Brismar K, Poellinger L, Pereira TS. Acute hypoxia induces apoptosis of pancreatic beta-cell by activation of the unfolded protein response and upregulation of CHOP. CELL DEATH & DISEASE 2012 3: e322-
91 Calissendorff J, Gustafsson T, Holst JJ, Brismar K, Rojdmark S. Alcohol Intake and Its Effect on Some Appetite-Regulating Hormones in Man: Influence of Gastroprotection with Sucralfate. ENDOCRINE RESEARCH 2012 37:3 154-62
92 Alvarsson A, Sandgren B, Wendel C, Alvarsson M, Brismar K. A retrospective analysis of amputation rates in diabetic patients: can lower extremity amputations be further prevented?. CARDIOVASCULAR DIABETOLOGY 2012 11: 18-
93 Gu HF, Ma J, Gu KT, Brismar K. Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy. Frontiers in endocrinology 2012 3: 179-
94 Vasan SK, Fall T, Neville MJ, Antonisamy B, Fall CH, Geethanjali FS, Gu HF, Raghupathy P, Samuel P, Thomas N, Brismar K, Ingelsson E, Karpe F. Associations of Variants in FTO and Near MC4R With Obesity Traits in South Asian Indians. OBESITY 2012 20:11 2268-77
95 Ansurudeen I, Sunkari VG, Grunler J, Peters V, Schmitt CP, Catrina SB, Brismar K, Forsberg EA. Carnosine enhances diabetic wound healing in the db/db mouse model of type 2 diabetes. AMINO ACIDS 2012 43:1 127-34
96 Peters V, Schmitt CP, Zschocke J, Gross ML, Brismar K, Forsberg E. Carnosine treatment largely prevents alterations of renal carnosine metabolism in diabetic mice. AMINO ACIDS 2012 42:6 2411-6
97 Persson MF, Franzen S, Catrina SB, Dallner G, Hansell P, Brismar K, Palm F. Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes. DIABETOLOGIA 2012 55:5 1535-43
98 Kistner A, Rakow A, Legnevall L, Marchini G, Brismar K, Hall K, Vanpée M. Differences in insulin resistance markers between children born small for gestational age or born preterm appropriate for gestational age. Acta paediatrica (Oslo, Norway : 1992) 2012 101:12 1217-24
99 Sjogren P, Sierra-Johnson J, Kallings LV, Cederholm T, Kolak M, Halldin M, Brismar K, de Faire U, Hellenius ML, Fisher RM. Functional changes in adipose tissue in a randomised controlled trial of physical activity. LIPIDS IN HEALTH AND DISEASE 2012 11: 80-
100 Horova E, Prazny M, Kankova K, Brismar K, Gu HF. Genetic and Functional Analyses of MRAS and HNF1A Genes in Diabetes and Diabetic Nephropathy. FOLIA BIOLOGICA 2012 58:3 121-7
101 Gu TW, Horova E, Mollsten A, Abu Seman N, Falhammar H, Prazny M, Brismar K, Gu HF. IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy. JOURNAL OF DIABETES AND ITS COMPLICATIONS 2012 26:5 393-8
102 Seed Ahmed M, Kovoor A, Nordman S, Abu Seman N, Gu T, Efendic S, Brismar K, Östenson CG, Gu HF. Increased expression of adenylyl cyclase 3 in pancreatic islets and central nervous system of diabetic Goto-Kakizaki rats: a possible regulatory role in glucose homeostasis. Islets 2012 4:5 343-8
103 Torffvit O, Kalani M, Apelqvist J, Eliasson B, Eriksson JW, Brismar K, Jörneskog G. Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes. Biochemistry research international 2012 2012: 480529-
104 Bentinger M, Tekle M, Dallner G, Brismar K, Gustafsson JA, Steffensen KR, Catrina SB. Influence of liver-X-receptor on tissue cholesterol, coenzyme Q and dolichol content. MOLECULAR MEMBRANE BIOLOGY 2012 29:7 299-308
105 Andreasson AN, Unden AL, Elofsson S, Brismar K. Leptin and adiponectin: Distribution and associations with cardiovascular risk factors in men and women of the general population. AMERICAN JOURNAL OF HUMAN BIOLOGY 2012 24:5 595-601
106 Deleskog A, Hilding A, Brismar K, Hamsten A, Efendic S, Ostenson CG. Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. DIABETOLOGIA 2012 55:6 1668-78
107 Sandholm N, Salem RM, McKnight AJ, Brennan EP, Forsblom C, Isakova T, McKay GJ, Williams WW, Sadlier DM, Makinen VP, Swan EJ, Palmer C, Boright AP, Ahlqvist E, Deshmukh HA, Keller BJ, Huang HT, Ahola AJ, Fagerholm E, Gordin D, Harjutsalo V, He B, Heikkila O, Hietala K, Kyto J, Lahermo P, Lehto M, Lithovius R, Osterholm AM, Parkkonen M, Pitkaniemi J, Rosengard-Barlund M, Saraheimo M, Sarti C, Soderlund J, Soro-Paavonen A, Syreeni A, Thorn LM, Tikkanen H, Tolonen N, Tryggvason K, Tuomilehto J, Waden J, Gill GV, Prior S, Guiducci C, Mirel DB, Taylor A, Hosseini SM, Parving HH, Rossing P, Tarnow L, Ladenvall C, Alhenc-Gelas F, Lefebvre P, Rigalleau V, Roussel R, Tregouet DA, Maestroni A, Maestroni S, Falhammar H, Gu TW, Mollsten A, Cimponeriu D, Ioana M, Mota M, Mota E, Serafinceanu C, Stavarachi M, Hanson RL, Nelson RG, Kretzler M, Colhoun HM, Panduru NM, Gu HF, Brismar K, Zerbini G, Hadjadj S, Marre M, Groop L, Lajer M, Bull SB, Waggott D, Paterson AD, Savage DA, Bain SC, Martin F, Hirschhorn JN, Godson C, Florez JC, Groop PH, Maxwell AP, DCCT-EDIC Res Grp. New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes. PLOS GENETICS 2012 8:9 e1002921-
108 Rafnsson A, Bohm F, Settergren M, Gonon A, Brismar K, Pernow J. The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial. DIABETOLOGIA 2012 55:3 600-7
109 Wang J, Razuvaev A, Folkersen L, Hedin E, Roy J, Brismar K, Hedin U. The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of IGF binding protein-1 in the regulation of smooth muscle cell proliferation. ATHEROSCLEROSIS 2012 220:1 102-9
110 Vasan SK, Neville MJ, Antonisamy B, Samuel P, Fall CH, Geethanjali FS, Thomas N, Raghupathy P, Brismar K, Karpe F. Absence of Birth-Weight Lowering Effect of ADCY5 and Near CCNL, but Association of Impaired Glucose-Insulin Homeostasis with ADCY5 in Asian Indians. PLOS ONE 2011 6:6 e21331-
111 Cooray G, Nilsson E, Wahlin A, Laukka EJ, Brismar K, Brismar T. Effects of intensified metabolic control on CNS function in type 2 diabetes. PSYCHONEUROENDOCRINOLOGY 2011 36:1 77-86
112 Nikoshkov A, Sunkari V, Savu O, Forsberg E, Catrina SB, Brismar K. Epigenetic DNA methylation in the promoters of the Igf1 receptor and insulin receptor genes in db/db mice. EPIGENETICS 2011 6:4 405-9
113 Gu HF, Gu T, Ostenson CG, Karvestedt L, Brismar K. Evaluation of Sox2 genetic effect on the development of type 2 diabetes. GENE 2011 486:1-2 94-6
114 Zhang DY, Gu TW, Forsberg E, Efendic S, Brismar K, Gu HF. Genetic and Functional Effects of Membrane Metalloendopeptidase on Diabetic Nephropathy Development. AMERICAN JOURNAL OF NEPHROLOGY 2011 34:5 483-90
115 Brandt K, Lundell K, Brismar K. Neutrophil-derived azurocidin cleaves insulin-like growth factor-binding protein-1,-2 and-4. GROWTH HORMONE & IGF RESEARCH 2011 21:3 167-73
116 Karvestedt L, Martensson E, Grill V, Elofsson S, von Wendt G, Hamsten A, Brismar K. The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden. JOURNAL OF DIABETES AND ITS COMPLICATIONS 2011 25:2 97-106
117 Engvall IL, Brismar K, Hafstrom I, Tengstrand B. Treatment with low-dose prednisolone is associated with altered body composition but no difference in bone mineral density in rheumatoid arthritis patients: a controlled cross-sectional study. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 2011 40:3 161-8
118 Spectre G, Arnetz L, Ostenson CG, Brismar K, Li NL, Hjemdahl P. Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications. THROMBOSIS AND HAEMOSTASIS 2011 106:3 491-9
119 Ekberg NR, Brismar K, Malmstedt J, Hedblad MA, Adamson U, Ungerstedt U, Wisniewski N. Analyte flux at a biomaterial-tissue interface over time: implications for sensors for type 1 and 2 diabetes mellitus. Journal of diabetes science and technology 2010 4:5 1063-72
120 Andreasson AN, Jernelov S, Szulkin R, Unden AL, Brismar K, Lekander M. Associations Between Leptin and Self-Rated Health in Men and Women. GENDER MEDICINE 2010 7:3 261-9
121 Mellbin LG, Ryden L, Brismar K, Morgenthaler NG, Ohrvik J, Catrina SB. Copeptin, IGFBP-1, and Cardiovascular Prognosis in Patients With Type 2 Diabetes and Acute Myocardial Infarction A report from the DIGAMI 2 trial. DIABETES CARE 2010 33:7 1604-6
122 Hilner JE, Perdue LH, Sides EG, Pierce JJ, Wägner AM, Aldrich A, Loth A, Albret L, Wagenknecht LE, Nierras C, Akolkar B, T1DGC. Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC). Clinical trials (London, England) 2010 7:1 Suppl S5-S32
123 Zhang DY, Efendic S, Brismar K, Gu HF. Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus. BMC MEDICAL GENETICS 2010 11: 116-
124 Ehrsson YT, Hellstrom PM, Brismar K, Sharp L, Langius-Eklof A, Laurell G. Explorative study on the predictive value of systematic inflammatory and metabolic markers on weight loss in head and neck cancer patients undergoing radiotherapy. SUPPORTIVE CARE IN CANCER 2010 18:11 1385-91
125 Lewitt MS, Hilding A, Brismar K, Efendic S, Ostenson CG, Hall K. IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women. EUROPEAN JOURNAL OF ENDOCRINOLOGY 2010 163:2 233-42
126 Engvall IL, Tengstrand B, Brismar K, Hafstrom I. Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months. ARTHRITIS RESEARCH & THERAPY 2010 12:5 R197-
127 Lindgren BF, Jacobson SH, Brismar K. Insulin-glucose infusion given before hemodialysis increases IGF-I in type 2 diabetes patients with chronic kidney disease. GROWTH HORMONE & IGF RESEARCH 2010 20:6 422-6
128 Olausson H, Lof M, Brismar K, Forsum E, Sohlstrom A. Maternal serum concentrations of insulin-like growth factor (IGF)-I and IGF binding protein-1 before and during pregnancy in relation to maternal body weight and composition and infant birth weight. BRITISH JOURNAL OF NUTRITION 2010 104:6 842-8
129 Leibiger IB, Brismar K, Berggren PO. Novel aspects on pancreatic beta-cell signal-transduction. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2010 396:1 111-5
130 Edstrom DW, Linder J, Wennersten G, Brismar K, Ros AM. Phototherapy with ultraviolet radiation: a study of hormone parameters and psychological effects. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2010 24:4 403-9
131 Tekle M, Gromadzinska J, Joksic G, Antic R, Nilsson R, Dallner G, Unden AL, Brismar K. Plasma levels of insulin-like growth factor-I, insulin-like growth factor binding protein-1, coenzyme Q10 and vitamin E in female populations from Poland, Serbia and Sweden. ENVIRONMENT INTERNATIONAL 2010 36:2 188-94
132 Gustavsson C, Yassin K, Wahlstrom E, Cheung L, Lindberg J, Brismar K, Ostenson CG, Norstedt G, Tollet-Egnell P. Sex-different hepaticglycogen content and glucose output in rats. BMC BIOCHEMISTRY 2010 11: 38-
133 Rehman JU, Brismar K, Holmback U, Akerstedt T, Axelsson J. Sleeping during the day: effects on the 24-h patterns of IGF-binding protein 1, insulin, glucose, cortisol, and growth hormone. EUROPEAN JOURNAL OF ENDOCRINOLOGY 2010 163:3 383-90
134 Gu HF, Alvarsson A, Brismar K. The Common FTO Genetic Polymorphism rs9939609 is Associated with Increased BMI in Type 1 Diabetes but not with Diabetic Nephropathy. Biomarker insights 2010 5: 29-32
135 Aronsson A, Al-Ani NA, Brismar K, Hedstrom M. A carbohydrate-rich drink shortly before surgery affected IGF-I bioavailability after a total hip replacement. A double-blind placebo controlled study on 29 patients. AGING CLINICAL AND EXPERIMENTAL RESEARCH 2009 21:2 97-101
136 Edmonds M, European Australian Apligraf. Apligraf in the Treatment of Neuropathic Diabetic Foot Ulcers. INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS 2009 8:1 11-8
137 Wu XP, Niu NF, Brismar K, Zhu XL, Wang X, Efendic S, Du T, Liu Y, Gu HF, Liu Y. Apolipoprotein M promoter polymorphisms alter promoter activity and confer the susceptibility to the development of type 1 diabetes. CLINICAL BIOCHEMISTRY 2009 42:1-2 17-21
138 Zhang DY, Ma J, Brismar K, Efendic S, Gu HF. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study. JOURNAL OF DIABETES AND ITS COMPLICATIONS 2009 23:4 265-72
139 Gustavsson C, Parini P, Ostojic J, Cheung L, Hu J, Zadjali F, Tahir F, Brismar K, Norstedt G, Tollet-Egnell P. Cocoa Butter and Safflower Oil Elicit Different Effects on Hepatic Gene Expression and Lipid Metabolism in Rats. LIPIDS 2009 44:11 1011-27
140 Zhang D, Freedman BI, Flekac M, Santos E, Hicks PJ, Bowden DW, Efendic S, Brismar K, Gu HF. Evaluation of Genetic Association and Expression Reduction of TRPC1 in the Development of Diabetic Nephropathy. AMERICAN JOURNAL OF NEPHROLOGY 2009 29:3 244-51
141 Dahlman I, Nilsson M, Gu HF, Lecoeur C, Efendic S, Ostenson CG, Brismar K, Gustafsson JA, Froguel P, Vaxillaire M, Dahlman-Wright K, Steffensen KR. Functional and genetic analysis in type 2 diabetes of Liver X receptor alleles - a cohort study. BMC MEDICAL GENETICS 2009 10: 27-
142 Grigorescu F, Attaoua R, El Mkadem SA, Beleza S, Bohdanowicz-Pawlak A, Comas AB, Boulton A, Brismar K, Catrina S, Coculescu M, Escobar-Morreale H, Fica S, Gheorghiu M, Gomis R, Hanzu F, Jobling M, Khusnutdinova E, Milewicz A, Nosicov V, Novials A, Pasquali R, Pascual G, Pirags V, Radian S, Rayaz M, Rocha J, Sesti G, Muller-Wieland D. HAPLOGENDIS INITIATIVE - SICA. ACTA ENDOCRINOLOGICA-BUCHAREST 2009 5:1 143-148
143 Hagmar M, Berglund B, Brismar K, Hirschberg AL. Hyperandrogenism May Explain Reproductive Dysfunction in Olympic Athletes. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE 2009 41:6 1241-8
144 Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Malarstig A, Brismar K, Hamsten A, Fisher RM, Hellenius ML. IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome. CLINICAL SCIENCE 2009 116:5-6 507-12
145 Brismar K, Nilsson SE. Interrelations and Associations of Serum Levels of Steroids and Pituitary Hormones with Markers of Insulin Resistance, Inflammatory Activity, and Renal Function in Men and Women Aged > 70 Years in an 8-Year Longitudinal Study of Opposite-Sex Twins. GENDER MEDICINE 2009 6: 123-36
146 Petersson U, Ostgren CJ, Brudin L, Brismar K, Nilsson PM. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): The Soderakra Cardiovascular Risk Factor Study. DIABETES & METABOLISM 2009 35:3 198-205
147 Irving GF, Freund-Levi Y, Eriksdotter-Joenhagen M, Basun H, Brismar K, Hjorth E, Palmblad J, Vessby B, Vedin I, Wahlund LO, Cederholm T. Omega-3 Fatty Acid Supplementation Effects on Weight and Appetite in Patients with Alzheimer's Disease: The Omega-3 Alzheimer's Disease Study. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY 2009 57:1 11-7
148 Karvestedt L, Martensson E, Grill V, Elofsson S, von Wendt G, Hamsten A, Brismar K. Peripheral Sensory Neuropathy Associates With Micro- or Macroangiopatly Results from a population-based study of type 2 diabetic patients in Sweden. DIABETES CARE 2009 32:2 317-22
149 Nilsson SE, Fransson E, Brismar K. Relationship Between Serum Progesterone Concentrations and Cardiovascular Disease, Diabetes, and Mortality in Elderly Swedish Men and Women: An 8-Year Prospective Study. GENDER MEDICINE 2009 6:3 433-43
150 Gu HF, Alvarsson A, Efendic S, Brismar K. SOX2 Has Gender-Specific Genetic Effects on Diabetic Nephropathy in Samples From Patients With Type 1 Diabetes Mellitus in the GoKinD Study. GENDER MEDICINE 2009 6:4 555-64
151 Engvall IL, Elkan AC, Tengstrand B, Cederholm T, Brismar K, Hafstrom I. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 2008 37:5 321-8
152 Boquist S, Ruotolo G, Skoglund-Andersson C, Tang R, Bjorkegren J, Bond MG, de Faire U, Brismar K, Hamsten A. Correlation of serum lGF-I and IGFBP-1 and-3 to cardiovascular risk indicators and early carotid atherosclerosis in healthy middle-aged men. CLINICAL ENDOCRINOLOGY 2008 68:1 51-8
153 Catrina SB, Rotarus R, Botusan IR, Coculescu M, Brismar K. Desmopressin increases IGF-binding protein-1 in humans. EUROPEAN JOURNAL OF ENDOCRINOLOGY 2008 158:4 479-82
154 Ahmad T, Ugarph-Morawski A, Lewitt MS, Li J, Saaf M, Brismar K. Diabetic osteopathy and the IGF system in the Goto-Kakizaki rat. GROWTH HORMONE & IGF RESEARCH 2008 18:5 404-411
155 Settergren M, Pernow J, Brismar K, Jorneskog G, Kalani M. Endothelin-A receptor blockade increases nutritive skin capillary circulation in patients with type 2 diabetes and microangiopathy. JOURNAL OF VASCULAR RESEARCH 2008 45:4 295-302
156 Dahlman I, Vaxillaire M, Nilsson M, Lecoeur C, Gu HF, Cavalcanti-Proenca C, Efendic S, Ostenson CG, Brismar K, Charpentler G, Gustafsson JA, Froguel P, Dahlman-Wright K, Steffensen KR. Estrogen receptor alpha gene variants associate with type 2 diabetes and fasting plasma glucose. PHARMACOGENETICS AND GENOMICS 2008 18:11 967-75
157 Ma J, Zhang D, Brismar K, Efendic S, Gu HF. Evaluation of the association between the common E469K polymorphism in the ICAM-I gene and diabetic nephropathy among type I diabetic patients in GoKinD population. BMC MEDICAL GENETICS 2008 9: 47-
158 Unden AL, Elofsson S, Andreasson A, Hillered E, Eriksson I, Brismar K. Gender differences in self-rated health, quality of life, quality of care, and metabolic control in patients with diabetes. GENDER MEDICINE 2008 5:2 162-80
159 Engvall IL, Svensson B, Tengstrand B, Brismar K, Hafstrom I, BARFOT Study Grp. Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study. ARTHRITIS RESEARCH & THERAPY 2008 10:6 R128-
160 Strawbridge RJ, Nister M, Brismar K, Li CD, Lindstrom S. Influence of MUC1 genetic variation on prostate cancer risk and survival. EUROPEAN JOURNAL OF HUMAN GENETICS 2008 16:12 1521-5
161 Kotronen A, Lewitt M, Hall K, Brismar K, Yki-Jarvinen H. Insulin-Like Growth Factor Binding Protein 1 as a Novel Specific Marker of Hepatic Insulin Sensitivity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 2008 93:12 4867-72
162 Lewitt MS, Hilding A, Ostenson CG, Efendic S, Brismar K, Hall K. Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. DIABETOLOGIA 2008 51:7 1135-45
163 Zheng X, Linke S, Dias JM, Zheng X, Gradin K, Wallis TP, Hamilton BR, Gustafsson M, Ruas JL, Wilkins S, Bilton RL, Brismar K, Whitelaw ML, Pereira T, Gorman JJ, Ericson J, Peet DJ, Lendahl U, Poellinger L. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2008 105:9 3368-73
164 Olausson H, Lof M, Brismar K, Lewitt M, Forsum E, Sohlstrom A. Longitudinal study of the maternal insulin-like growth factor system before, during and after pregnancy in relation to fetal and infant weight. HORMONE RESEARCH 2008 69:2 99-106
165 Strawbridge RJ, Nistér M, Brismar K, Grönberg H, Li C. MUC1 as a Putative Prognostic Marker for Prostate Cancer. Biomarker insights 2008 3: 303-315
166 Efendic S, Alvarsson M, Brismar K, Wagner H. Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs. ACTA PHYSIOLOGICA 2008 192:1 117-25
167 Bentinger M, Tekle M, Brismar K, Chojnacki T, Swiezewska E, Dallner G. Polyisoprenoid epoxides stimulate the biosynthesis of coenzyme Q and inhibit cholesterol synthesis. JOURNAL OF BIOLOGICAL CHEMISTRY 2008 283:21 14645-53
168 Lehtihet M, Efendic S, Brismar K. Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes. CLINICAL SCIENCE 2008 115:5-6 167-74
169 Sjöholm A, Agardh CD, Brismar K, Efendic S, Eliasson B, Eriksson JW, Frid A, Groop L, Holmgren J, Ridderstråle M, Smith U. [Reply on new drugs against type 2 diabetes: important to gain experience and knowledge]. Lakartidningen 2008 105:17-18 1310-1312
170 Jonasson JM, Ye W, Sparen P, Apelqvist J, Nyren O, Brismar K. Risks of nontraumatic lower-extremity amputations in patients with type 1 diabetes - A population-based cohort study in Sweden. DIABETES CARE 2008 31:8 1536-40
171 Botusan IR, Sunkari VG, Savu O, Catrina AI, Grunler J, Lindberg S, Pereira T, Yla-Herttuala S, Poellinger L, Brismar K, Catrina SB. Stabilization of HIF-1 alpha is critical to improve wound healing in diabetic mice. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2008 105:49 19426-31
172 Bentinger M, Tekle M, Brismar K, Chojnacki T, Swiezewska E, Dallner G. Stimulation of coenzyme Q synthesis. BIOFACTORS 2008 32:1-4 99-111
173 Mollsten A, Kockum I, Svensson M, Rudberg S, Ugarph-Morawski A, Brismar K, Eriksson JW, Dahlquist G. The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk. JOURNAL OF DIABETES AND ITS COMPLICATIONS 2008 22:6 377-83
174 Mollsten A, Marklund SL, Wessman M, Svensson M, Forsblom C, Parkkonen M, Brismar K, Groop PH, Dahlquist G. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. DIABETES 2007 56:1 265-9
175 Wallin MKEB, Sellden E, Eksborg S, Brismar K. Amino acid infusion during anesthesia attenuates the surgery induced decline in IGF-1 and diminishes the "diabetes of injury". NUTRITION & METABOLISM 2007 4: 2-
176 Ma J, Nordman S, Mollsten A, Falhammar H, Brismar K, Dahlquist G, Efendic S, Gu HF. Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type I diabetes and diabetic nephropathy among Swedish and American populations. EUROPEAN JOURNAL OF ENDOCRINOLOGY 2007 157:5 641-5
177 Jonasson JM, Brismar K, Sparen P, Lambe M, Nyren O, Ostenson CG, Ye WM. Fertility in women with type 1 diabetes - A population-based cohort study in Sweden. DIABETES CARE 2007 30:9 2271-6
178 Ma J, Mollsten A, Falhammar H, Brismar K, Dahlquist G, Efendic S, Gu HF. Genetic association analysis of the adiponectin polymorphisms in type 1 diabetes with and without diabetic nephropathy. JOURNAL OF DIABETES AND ITS COMPLICATIONS 2007 21:1 28-33
179 Strawbridge RJ, Karvestedt L, Li C, Efendic S, Ostenson CG, Gu HF, Brismar K. GHR exon 3 polymorphism: Association with type 2 diabetes mellitus and metabolic disorder. GROWTH HORMONE & IGF RESEARCH 2007 17:5 392-8
180 Wallander M, Norhammar A, Malmberg K, Ohrvik J, Ryden L, Brismar K. IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes. DIABETES CARE 2007 30:9 2343-8
181 Unden AL, Andreasson A, Elofsson S, Brismar K, Mathsson L, Ronnelid J, Lekander M. Inflammatory cytokines, behaviour and age as determinants of self-rated health in women. CLINICAL SCIENCE 2007 112:5-6 363-73
182 Persson M, Hytter-Landah A, Brismar K, Cederholm T. Nutritional supplementation and dietary advice in geriatric patients at risk of malnutrition. CLINICAL NUTRITION 2007 26:2 216-24
183 Anderson RE, Brismar K, Ivert T. Only a minority of patients referred for elective coronary artery bypass surgery have risk factors diagnosed and treated according to established guidelines. Diabetes & vascular disease research 2007 4:2 112-6
184 Anderson RE, Brismar K, Lindberg A, Hylander S, Alserius T, Ivert T. [Poor control of risk factors prior to heart surgery. High proportion of undiscovered diabetes, undertreated hypertension and hyperlipidemia]. Lakartidningen 2007 104:12 936-40
185 Bentinger M, Brismar K, Dallner G. The antioxidant role of coenzyme Q. MITOCHONDRION 2007 7: S41-50
186 Calissendorff J, Danielsson O, Brismar K, Rojdmark S. Alcohol ingestion does not affect serum levels of peptide YY but decreases both total and octanoylated ghrelin levels in healthy subjects. METABOLISM-CLINICAL AND EXPERIMENTAL 2006 55:12 1625-9
187 Larsson SC, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. DIABETOLOGIA 2006 49:12 2819-23
188 Ma J, Mollsten A, Prazny M, Falhammar H, Brismar K, Dahlquist G, Efendic S, Gu HF. Genetic influences of the intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in development of Type 1 diabetes and diabetic nephropathy. DIABETIC MEDICINE 2006 23:10 1093-9
189 Mollsten A, Wessman M, Svensson M, Forsblom C, Parkkonen M, Brismar K, Groop PH, Dahlquist G. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy. ANNALS OF MEDICINE 2006 38:7 522-8
190 Catrina SB, Botusan IR, Rantanen A, Catrina AI, Pyakurel P, Savu O, Axelson M, Biberfeld P, Poellinger L, Brismar K. Hypoxia-inducible factor-1 alpha- and hypoxia-inducible factor-2 alpha are expressed in Kaposi sarcoma and modulated by insulin-like growth factor-I. CLINICAL CANCER RESEARCH 2006 12:15 4506-14
191 Wallander M, Brismar K, Ohrvik J, Ryden L, Norhammar A. Insulin-like growth factor I: a predictor of long-term glucose abnormalities in patients with acute myocardial infarction. DIABETOLOGIA 2006 49:10 2247-55
192 Heald AH, Karvestedt L, Anderson SG, McLaughlin J, Knowles A, Wong L, Grill V, Cruickshank JK, White A, Gibson M, Brismar K. Low insulin-like growth factor-II levels predict weight gain in normal weight subjects with Type 2 diabetes. AMERICAN JOURNAL OF MEDICINE 2006 119:2 167.e9-15
193 Olausson H, Lewitt M, Brismar K, Uvnas-Moberg K, Sohlstrom A. Maternal food restriction during gestation elevates insulin-like growth factor I and insulin-like growth factor binding protein 1 in adult male rat offspring. NUTRITION RESEARCH 2006 26:7 350-355
194 Wang J, Shafqat J, Hall K, Stahlberg M, Wivall-Helleryd IL, Bouzakri K, Zierath JR, Brismar K, Jornvall H, Lewitt MS. Specific cleavage of insulin-like growth factor-binding protein-1 by a novel protease activity. CELLULAR AND MOLECULAR LIFE SCIENCES 2006 63:19-20 2405-14
195 Lewitt MS, Hall K, Bang P, Brismar K. Altered response of insulin-like growth factor-binding protein 1 to nutritional deprivation in type 2 diabetes mellitus. METABOLISM-CLINICAL AND EXPERIMENTAL 2005 54:3 275-80
196 Larsson SC, Wolk K, Brismar K, Wolk A. Association of diet with serum insulin-like growth factor I in middleaged and elderly men. AMERICAN JOURNAL OF CLINICAL NUTRITION 2005 81:5 1163-7
197 Jorneskog G, Kalani M, Kuhl J, Bavenholm P, Katz A, Allerstrand G, Alvarsson M, Efendic S, Ostenson CG, Pernow J, Wahren J, Brismar K. Early microvascular dysfunction in healthy normal-weight males with heredity for type 2 diabetes. DIABETES CARE 2005 28:6 1495-7
198 Anderson RE, Brismar K, Barr G, Ivert T. Effects of cardiopulmonary bypass on glucose homeostasis after coronary artery bypass surgery. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY 2005 28:3 425-30
199 Anderson RE, Ehrenberg J, Barr G, Brismar K, Owall A, Alserius T, Ivert T. Effects of thoracic epidural analgesia on glucose homeostasis after cardiac surgery in patients with and without diabetes mellitus. EUROPEAN JOURNAL OF ANAESTHESIOLOGY 2005 22:7 524-9
200 Miao JM, Brismar K, Nyren O, Ugarph-Morawski A, Ye WM. Elevated hip fracture risk in type 1 diabetic patients. DIABETES CARE 2005 28:12 2850-5
201 Unden AL, Elofsson S, Brismar K. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study. CLINICAL ENDOCRINOLOGY 2005 63:1 94-102
202 Rojdmark S, Calissendorff J, Danielsson O, Brismar K. Hunger-satiety signals in patients with Graves' thyrotoxicosis before, during, and after long-term pharmacological treatment. ENDOCRINE 2005 27:1 55-61
203 Ursing C, von Bahr C, Brismar K, Rojdmark S. Influence of cigarette smoking on melatonin levels in man. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2005 61:3 197-201
204 Calissendorff J, Danielsson O, Brismar K, Rojdmark S. Inhibitory effect of alcohol on ghrelin secretion in normal man. EUROPEAN JOURNAL OF ENDOCRINOLOGY 2005 152:5 743-7
205 Catrina SB, Lewitt M, Massambu C, Dricu A, Grunler J, Axelson M, Biberfeld P, Brismar K. Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival. BRITISH JOURNAL OF CANCER 2005 92:8 1467-74
206 Nordman S, Ding B, Ostenson CG, Karvestedt L, Brismar K, Efendic S, Gu HF. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES 2005 113:5 282-7
207 Ekberg NR, Wisniewski N, Brismar K, Ungerstedt U. Measurement of glucose and metabolites in subcutaneous adipose tissue during hyperglycemia with microdialysis at various perfusion flow rates. CLINICA CHIMICA ACTA 2005 359:1-2 53-64
208 Rajamand N, Ungerstedt U, Brismar K. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus. DIABETES OBESITY & METABOLISM 2005 7:5 525-35
209 . 40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004. Diabetologia 2004 47:Suppl 1 A1-A464
210 Dricu A, Sergiu-Bogdan C, Brismar K, Biberfeld P, Andersson LC. A synthetic peptide derived from the human eosinophil-derived neurotoxin induces apoptosis in Kaposi's sarcoma cells. ANTICANCER RESEARCH 2004 24:3A 1427-32
211 Tidermark J, Ponzer S, Carlsson P, Soderqvist A, Brismar K, Tengstrand B, Cederholm T. Effects of protein-rich supplementation and nandrolone in lean elderly women with femoral neck fractures. CLINICAL NUTRITION 2004 23:4 587-96
212 Catrina SB, Okamoto K, Pereira T, Brismar K, Poellinger L. Hyperglycentia regulates hypoxia-inducible factor-1 alpha protein stability and function. DIABETES 2004 53:12 3226-32
213 Kistner A, Jacobson SH, Celsi G, Vanpee M, Brismar K. IGFBP-1 levels in adult women born small for gestational age suggest insulin resistance in spite of normal BMI. JOURNAL OF INTERNAL MEDICINE 2004 255:1 82-8
214 Calissendorff J, Brismar K, Rojdmark S. Is decreased leptin secretion after alcohol ingestion catecholamine-mediated?. ALCOHOL AND ALCOHOLISM 2004 39:4 281-6
215 Wolk K, Larsson SC, Vessby B, Wolk A, Brismar K. Metabolic, anthropometric, and nutritional factors as predictors of circulating insulin-like growth factor binding protein-1 levels in middle-aged and elderly men. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 2004 89:4 1879-84
216 Bensing S, Rorsman F, Crock P, Sanjeevi C, Ericson K, Kampe O, Brismar K, Hulting AL. No evidence for Autoimmunity as a major cause of the empty Sella syndrome. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES 2004 112:5 231-5
217 Gu HF, Efendic S, Nordman S, Ostenson CG, Brismar K, Brookes AJ, Prince JA. Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels. DIABETES 2004 53:8 2137-42
218 Riserus U, Arnlov J, Brismar K, Zethelius B, Berglund L, Vessby B. Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. DIABETES CARE 2004 27:8 2041-6
219 Catrina SB, Rotarus R, Wivall IL, Coculescu M, Brismar K. The influence of vasopressin deficiency and acute desmopressin administration on melatonin secretion in patients with central diabetes insipidus. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2004 27:1 47-51
220 Ursing C, Wikner J, Brismar K, Rojdmark S. Caffeine raises the serum melatonin level in healthy subjects: An indication of melatonin metabolism by cytochrome P450(CYP)1A2. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2003 26:5 403-6
221 Kalani M, Apelqvist J, Blomback M, Brismar K, Eliasson B, Eriksson JW, Fagrell B, Hamsten A, Torffvit O, Jorneskog G. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease - A prospective, randomized, double-blind, placebo-controlled study. DIABETES CARE 2003 26:9 2575-80
222 Svanfeldt M, Thorell A, Brismar K, Nygren J, Ljungqvist O. Effects of 3 days of 'postoperative' low caloric feeding with or without bed rest on insulin sensitivity in healthy subjects. CLINICAL NUTRITION 2003 22:1 31-8
223 Dallner G, Brismar K, Chojnacki T, Swiezewska E. Regulation of coenzyme Q biosynthesis and breakdown. BIOFACTORS 2003 18:1-4 11-22
224 Hubinette A, Lichtenstein P, Brismar K, Vatten L, Jacobsen G, Ekbom A, Cnattingius S. Serum insulin-like growth factors in normal pregnancy and in pregnancies complicated by preeclampsia. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 2003 82:11 1004-9
225 Weiderpass E, Brismar K, Bellocco R, Vainio H, Kaaks R. Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk. BRITISH JOURNAL OF CANCER 2003 89:9 1697-704
226 Degerblad M, Brismar K, Rahn T, Thoren M. The hypothalamus-pituitary function after pituitary stereotactic radiosurgery: evaluation of growth hormone deficiency. JOURNAL OF INTERNAL MEDICINE 2003 253:4 454-62
227 Wallin M, Barr G, Owall A, Lindahl SGE, Brismar K. The influence of glucose-insulin-potassium (GIK) on the GH/IGF-1/IGFBP-1 axis during elective coronary artery bypass surgery. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA 2003 17:4 470-7
228 Klareskog L, Efendic S, Brismar K, Hamsten A. [The proposal of the National Board of Health and Welfare counteracts knowledge development within health care]. Lakartidningen 2003 100:8 631-2
229 Turunen M, Wehlin L, Sjoberg M, Lundahl J, Dallner G, Brismar K, Sindelar PJ. beta 2-integrin and lipid modifications indicate a non-antioxidant mechanism for the anti-atherogenic effect of dietary coenzyme Q10. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2002 296:2 255-60
230 van Setten G, Brismar K, Algvere P. Elevated intraocular levels of insulin-like growth factor I in a diabetic patient with acromegaly. Orbit (Amsterdam, Netherlands) 2002 21:2 161-7
231 Lewitt MS, Brismar K. Gender difference in the leptin response to feeding in peroxisome-proliferator-activated receptor-alpha knockout mice. INTERNATIONAL JOURNAL OF OBESITY 2002 26:10 1296-300
232 Nygren J, Thorell A, Brismar K, Essen P, Wernerman J, McNurlan MA, Garlick PJ, Ljungqvist O. Glucose flux is normalized by compensatory hyperinsulinaemia in growth hormone-induced insulin resistance in healthy subjects, while skeletal muscle protein synthesis remains unchanged. CLINICAL SCIENCE 2002 102:4 457-64
233 Kalani M, Jorneskog G, Naderi N, Lind F, Brismar K. Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers - Long-term follow-up. JOURNAL OF DIABETES AND ITS COMPLICATIONS 2002 16:2 153-8
234 Unden AL, Elofsson S, Knox S, Lewitt MS, Brismar K. IGF-I in a normal population: relation to psychosocial factors. CLINICAL ENDOCRINOLOGY 2002 57:6 793-803
235 Halldin MU, Brismar K, Tuvemo T, Gustafsson J. Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment. CLINICAL ENDOCRINOLOGY 2002 57:6 735-43
236 Sohlstrom A, Olausson H, Brismar K, Uvnas-Moberg K. Oxytocin treatment during early life influences reproductive performance in ad libitum fed and food-restricted female rats. BIOLOGY OF THE NEONATE 2002 81:2 132-8
237 Bennet AM, Brismar K, Hallqvist J, Reuterwall C, de Faire U. The risk of myocardial infarction is enhanced by a synergistic interaction between serum insulin and smoking. EUROPEAN JOURNAL OF ENDOCRINOLOGY 2002 147:5 641-7
238 Riserus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic add causes isomerm-specific insulin resistance in obese men with the metabolic syndrome. DIABETES CARE 2002 25:9 1516-21
239 Rojdmark S, Calissendorff J, Brismar K. Alcohol ingestion decreases both diurnal and nocturnal secretion of leptin in healthy individuals. CLINICAL ENDOCRINOLOGY 2001 55:5 639-47
240 Halldin MU, Aman J, Brismar K, Jones I, Tuvemo T, Gustafsson J. Anticholinergic treatment improves glycaemic control in adolescent girls with insulin-dependent diabetes mellitus. ACTA PAEDIATRICA 2001 90:4 393-9
241 Soderberg S, Olsson T, Eliasson M, Johnson O, Brismar K, Carlstrom K, Ahren B. A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing (central) adiposity. INTERNATIONAL JOURNAL OF OBESITY 2001 25:1 98-105
242 Soderberg S, Ahren B, Eliasson M, Dinesen B, Brismar K, Olsson T. Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women. EUROPEAN JOURNAL OF ENDOCRINOLOGY 2001 144:3 283-90
243 Jorneskog G, Djavani K, Brismar K. Day-to-day variability of transcutaneous oxygen tension in patients with diabetes mellitus and peripheral arterial occlusive disease. JOURNAL OF VASCULAR SURGERY 2001 34:2 277-82
244 Rojdmark S, Brismar K. Decreased IGF-I bioavailability after ethanol abuse in alcoholics: Partial restitution after short-term abstinence. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2001 24:7 476-82
245 Nygren J, Carlsson-Skwirut C, Brismar K, Thorell A, Ljungqvist O, Bang P. Insulin infusion increases levels of free IGF-I and IGFBP-3 proteolytic activity in patients after surgery. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 2001 281:4 E736-41
246 Lewitt MS, Brismar K, Ohlson J, Hartman J. Lithium chloride inhibits the expression and secretion of insulin-like growth factor-binding protein-1. JOURNAL OF ENDOCRINOLOGY 2001 171:3 R11-5
247 Lewitt MS, Brismar K, Wang J, Wivall-Helleryd IL, Sindelar P, Gonzalez FJ, Bergman T, Bobek GA. Responses of insulin-like growth factor (IGF)-I and IGF-binding proteins to nutritional status in peroxisome proliferator-activated receptor-alpha knockout mice. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2001 11:5 303-13
248 Zachrisson I, Brismar K, Carlsson-Skwirut C, Dahlquist G, Wallensteen M, Bang P. Increased 24 h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys. GROWTH HORMONE & IGF RESEARCH 2000 10:6 324-31
249 Zachrisson I, Dahlquist G, Wallensteen M, Brismar K. Insulin-like growth factor binding protein-1 as glucose regulator in adolescent boys with type 1 diabetes. ACTA PAEDIATRICA 2000 89:9 1044-9
250 Rojdmark S, Rydvald Y, Aquilonius A, Brismar K. Insulin-like growth factor (IGF)-1 and IGF-binding protein-1 concentrations in serum of normal subjects after alcohol ingestion: evidence for decreased IGF-1 bioavailability. CLINICAL ENDOCRINOLOGY 2000 52:3 313-8
251 Ruotolo G, Bavenholm P, Brismar K, Efendic S, Ericsson CG, de Faire U, Nilsson J, Hamsten A. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: Beneficial effects of bezafibrate treatment. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2000 35:3 647-54
252 Kanter-Lewensohn L, Girnita L, Girnita A, Dricu A, Olsson G, Leech L, Nilsson G, Hilding A, Wejde J, Brismar K, Larsson O. Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway. MOLECULAR AND CELLULAR ENDOCRINOLOGY 2000 165:1-2 131-7
253 Soop M, Nygren J, Brismar K, Thorell A, Ljungqvist O. The hyperinsulinaemic-euglycaemic glucose clamp: reproducibility and metabolic effects of prolonged insulin infusion in healthy subjects. CLINICAL SCIENCE 2000 98:4 367-74
254 Ahmed E, Nityanand S, Mustafa A, Brismar K, Lefvert AK. Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications. CLINICAL AND EXPERIMENTAL IMMUNOLOGY 1999 115:2 255-9
255 Sohlstrom A, Brismar K, Carlsson-Skwirut C, Bang P, Uvnas-Moberg K. Effects of oxytocin on the IGF-axis and some gastrointestinal hormones in ad libitum fed and food-restricted female rats. ACTA PHYSIOLOGICA SCANDINAVICA 1999 166:3 223-30
256 Sohlstrom A, Carlsson-Skwirut C, Bang P, Brismar K, Uvnas-Moberg K. Effects of oxytocin treatment early in pregnancy on fetal growth in ad libitum-fed and food-restricted rats. PEDIATRIC RESEARCH 1999 46:3 339-44
257 Hehenberger K, Hansson A, Heilborn JD, Abdel-Halim SM, Ostensson CG, Brismar K. Impaired proliferation and increased L-lactate production of dermal fibroblasts in the GK-rat, a spontaneous model of non-insulin dependent diabetes mellitus. WOUND REPAIR AND REGENERATION 1999 7:1 65-71
258 Signorello LB, Brismar K, Bergstrom R, Andersson SO, Wolk A, Trichopoulos D, Adami HO. Insulin-like growth factor-binding protein-1 and prostate cancer. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 1999 91:22 1965-7
259 Arver S, Jacobsson H, Cedermark B, Hamberger B, Lundell G, Grimelius L, Brismar K. Malignant human renin producing paraganglionoma-localization with I-123-MIBG and treatment with I-131-MIBG. CLINICAL ENDOCRINOLOGY 1999 51:5 631-5
260 Ponzer S, Tidermark J, Brismar K, Soderqvist A, Cederholm T. Nutritional status, insulin-like growth factor-1 and quality of life in elderly women with hip fractures. CLINICAL NUTRITION 1999 18:4 241-6
261 Fernqvist-Forbes E, Ekberg K, Lindgren BF, Brismar K. Splanchnic exchange of insulin-like growth factor binding protein-1 (IGFBP-1), IGF-I and acid-labile subunit (ALS) during normo- and hyper-insulinaemia in healthy subjects. CLINICAL ENDOCRINOLOGY 1999 51:3 327-32
262 Kalani M, Brismar K, Fagrell B, Ostergren J, Jorneskog G. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. DIABETES CARE 1999 22:1 147-51
263 Hehenberger K, Kratz G, Hansson A, Brismar K. Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin. JOURNAL OF DERMATOLOGICAL SCIENCE 1998 16:2 144-51
264 Hehenberger K, Heilborn JD, Brismar K, Hansson A. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 1998 6:2 135-41
265 Lemne C, Brismar K. Insulin-like growth factor binding protein-1 as a marker of the metabolic syndrome--a study in borderline hypertension. Blood pressure 1998 7:2 89-95
266 Clauson PG, Brismar K, Hall K, Linnarsson R, Grill V. Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION 1998 58:4 353-60
267 Nygren JO, Thorell A, Soop M, Efendic S, Brismar K, Karpe F, Nair KS, Ljungqvist O. Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 1998 275:1 E140-8
268 Jorneskog G, Brismar K, Fagrell B. Pronounced skin capillary ischemia in the feet of diabetic patients with bad metabolic control. DIABETOLOGIA 1998 41:4 410-5
269 Hong Y, Brismar K, Hall K, Pedersen NL, deFaire U. Associations between insulin-like growth factor-I (IGF-I), IGF-binding protein-1, insulin and other metabolic measures after controlling for genetic influences: Results from middle-aged and elderly monozygotic twins. JOURNAL OF ENDOCRINOLOGY 1997 153:2 251-7
270 Ostenson CG, Fiere V, Ahmed M, Lindstrom P, Brismar K, Brismar T, Kreicbergs A. Decreased cortical bone thickness in spontaneously non-insulin-dependent diabetic GK rats. JOURNAL OF DIABETES AND ITS COMPLICATIONS 1997 11:6 319-22
271 Zachrisson I, Brismar K, Hall K, Wallensteen M, Dahlqvist G. Determinants of growth in diabetic pubertal subjects. DIABETES CARE 1997 20:8 1261-5
272 Brismar K, Lind F, Kratz G. Dose-dependent hyperbaric oxygen stimulation of human fibroblast proliferation. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 1997 5:2 147-50
273 Cederholm T, Wretlind B, Hellstrom K, Andersson B, Engstrom L, Brismar K, Scheynius A, Forslid J, Palmblad J. Enhanced generation of interleukins 1 beta and 6 may contribute to the cachexia of chronic disease. AMERICAN JOURNAL OF CLINICAL NUTRITION 1997 65:3 876-82
274 Hong YL, Pedersen NL, Brismar K, deFaire U. Genetic and environmental architecture of the features of the insulin-resistance syndrome. AMERICAN JOURNAL OF HUMAN GENETICS 1997 60:1 143-52
275 FernqvistForbes E, Hilding A, Ekberg K, Brismar K. Influence of circulating epinephrine and norepinephrine on insulin-like growth factor binding protein-1 in humans. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 1997 82:8 2677-80
276 Nygren J, Thorell A, Brismar K, Karpe F, Ljungqvist O. Short-term hypocaloric nutrition but not bed rest decrease insulin sensitivity and IGF-I bioavailability in healthy subjects: The importance of glucagon. NUTRITION 1997 13:11-12 945-51
277 Jorneskog G, Egberg N, Fagrell B, Fatah K, Hessel B, Johnsson H, Brismar K, Blomback M. Altered properties of the fibrin gel structure in patients with IDDM. DIABETOLOGIA 1996 39:12 1519-23
278 Lindgren BF, OdarCederlof I, Ericsson F, Brismar K. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?. GROWTH REGULATION 1996 6:3 137-43
279 Hong YL, Pedersen NL, Brismar K, Hall K, deFaire U. Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-Binding protein-1 and insulin levels in middle-aged and elderly twins. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 1996 81:5 1791-7
280 HILDING A, BRISMAR K, DEGERBLAD M, THOREN M, HALL K. ALTERED RELATION BETWEEN CIRCULATING LEVELS OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 AND INSULIN IN GROWTH HORMONE-DEFICIENT PATIENTS AND INSULIN-DEPENDENT DIABETIC-PATIENTS COMPARED TO THAT IN HEALTHY-SUBJECTS. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 1995 80:9 2646-52
281 NYGREN J, SAMMANN M, MALM M, EFENDIC S, HALL K, BRISMAR K, LJUNGQVIST O. DISTURBED ANABOLIC HORMONAL PATTERNS IN BURNED PATIENTS - THE RELATION TO GLUCAGON. CLINICAL ENDOCRINOLOGY 1995 43:4 491-500
282 JORNESKOG G, BRISMAR K, FAGRELL B. SKIN CAPILLARY CIRCULATION IS MORE IMPAIRED IN THE TOES OF DIABETIC THAN NONDIABETIC PATIENTS WITH PERIPHERAL VASCULAR-DISEASE. DIABETIC MEDICINE 1995 12:1 36-41
283 JORNESKOG G, BRISMAR K, FAGRELL B. SKIN CAPILLARY CIRCULATION SEVERELY IMPAIRED IN TOES OF PATIENTS WITH IDDM, WITH AND WITHOUT LATE DIABETIC COMPLICATIONS. DIABETOLOGIA 1995 38:4 474-80

Review

1 Zhang XL, Abu Seman N, Falhammar H, Brismar K, Gu HF. Genetic and Biological Effects of ICAM-1 E469K Polymorphism in Diabetic Kidney Disease. JOURNAL OF DIABETES RESEARCH 2020 2020: 8305460-
2 Swartling C, Rystedt A, Brismar K, Naver H, Norman P, Dizdarevic A. [Hyperhidrosis is a silent handicap]. Ugeskrift for laeger 2016 178:6 V04150291-
3 Arnetz L, Dorkhan M, Alvarsson M, Brismar K, Ekberg NR. Gender differences in non-glycemic responses to improved insulin sensitivity by pioglitazone treatment in patients with type 2 diabetes. Acta diabetologica 2014 51:2 185-92
4 Gu HF, Brismar K. Genetic association studies in diabetic nephropathy. Current diabetes reviews 2012 8:5 336-44
5 Swartling C, Brismar K, Aquilonius SM, Naver H, Rystedt A, Rosell K. [Hyperhidrosis--the "silent" handicap]. Lakartidningen 2011 108:47 2428-32
6 Hall K, Bang P, Brismar K. [Insulin-like growth factors. Future treatment in catabolism?]. Lakartidningen 1995 92:26-27 2666-71
7 Brismar K, Hilding A, Lindgren B. Regulation of IGFBP-1 in humans. Progress in growth factor research 1995 6:2-4 449-56

Letter

1 Cederlöf M, Curman P, Ahanian T, Leong IUS, Brismar K, Bachar-Wikstrom E, Wikstrom JD. Darier disease is associated with type 1 diabetes: Findings from a population-based cohort study. Journal of the American Academy of Dermatology 2019 81:6 1425-1426
2 Hunt KA, Smyth DJ, Balschun T, Ban M, Mistry V, Ahmad T, Anand V, Barrett JC, Bhaw-Rosun L, Bockett NA, Brand OJ, Brouwer E, Concannon P, Cooper JD, Dias KR, van Diemen CC, Dubois PC, Edkins S, Fölster-Holst R, Fransen K, Glass DN, Heap GA, Hofmann S, Huizinga TW, Hunt S, Langford C, Lee J, Mansfield J, Marrosu MG, Mathew CG, Mein CA, Müller-Quernheim J, Nutland S, Onengut-Gumuscu S, Ouwehand W, Pearce K, Prescott NJ, Posthumus MD, Potter S, Rosati G, Sambrook J, Satsangi J, Schreiber S, Shtir C, Simmonds MJ, Sudman M, Thompson SD, Toes R, Trynka G, Vyse TJ, Walker NM, Weidinger S, Zhernakova A, Zoledziewska M, Weersma RK, Gough SC, Sawcer S, Wijmenga C, Parkes M, Cucca F, Franke A, Deloukas P, Rich SS, Todd JA, van Heel DA, Wellcome Trust Case Control Consortium, UK Inflammatory Bowel Disease (IBD) Genetics Consortium, Type 1 Diabetes Genetics Consortium. Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry. Nature genetics 2011 44:1 3-5
3 Gu HF, Efendic S, Brismar K. Lack of an association between GHR exon 3 polymorphism and diabetic nephropathy in the Genetics of Kidneys in Diabetes (GoKinD) population. DIABETOLOGIA 2008 51:12 2333-4
4 Catrina SB, Brismar K. Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects: response to Krishnan et al. Diabetes care 2008 31:2 e6-author
5 Catrina SB, Virtanen K, Hallsten K, Lonnqvist F, Nuutila P, Brismar K. Effect of rosiglitazone on early-morning plasma cortisol levels. NEUROENDOCRINOLOGY LETTERS 2005 26:6 763-4
6 Melkersson K, Hulting AL, Brismar K. Body weight gain, insulin, and leptin in olanzapine-treated patients - Reply. JOURNAL OF CLINICAL PSYCHIATRY 2001 62:11 903-904
7 Lemne C, Brismar K. Haemoglobin, haematocrit, and insulin resistance. DIABETIC MEDICINE 1996 13:11 1000-

Editorial

1 Valladolid-Acebes I, Daraio T, Brismar K, Hökfelt T, Bark C. Minor differences in the molecular machinery mediating regulated membrane fusion has major impact on metabolic health. Adipocyte 2016 5:3 318-25
2 Sunkari VG, Botusan IR, Savu O, Grünler J, Zheng X, Gustafsson JÅ, Brismar K, Catrina SB. Selective blockade of estrogen receptor beta improves wound healing in diabetes. Endocrine 2014 46:2 347-50

Other

1 Daraio T, Bombek LK, Gosak M, Valladolid-Acebes I, Klemen MS, Refai E, Berggren PO, Brismar K, Rupnik MS, Bark C. Investigating SNAP-25b (Synaptosomal-associated protein 25) function in mouse islet physiology beyond its classical role in membrane fusion. ACTA PHYSIOLOGICA 2017 221: 14-14
2 Hage CC, Bjerre M, Frystyk J, Gu H, Brismar K, Donal E, Daubert JC, Linde C, Lund LH. Serum IGFBP-7 is associated with diastolic dysfunction and predicts outcomes in heart failure and preserved ejection fraction. EUROPEAN JOURNAL OF HEART FAILURE 2017 19: 478-478
3 Dolensek J, Valladolid-Acebes I, Gosak M, Klemen MS, Bombek LK, Pohorec V, Berggren PO, Brismar K, Stozer A, Rupnik MS. Western Diet-Induced Early Dysfunction of Mouse Pancreatic Beta Cells. ACTA PHYSIOLOGICA 2017 221: 82-82
4 Ritsinger V, Brismar K, Malmberg K, Mellbin L, Nasman P, Ryden L, Soderberg S, Tenerz A, Norhammar A. Elevated levels of adipokines predict outcome after acute myocardial infarction. Long-term follow-up of the GAMI cohort. EUROPEAN HEART JOURNAL 2016 37: 459-459
5 Faxen UL, Hage C, Benson L, Zabarovskaja S, Andreasson A, Donal E, Daubert JC, Linde C, Brismar K, Lund LH. HFpEF and HFrEF display different anabolic phenotypes as assessed by IGF-1 and IGFBP-1. EUROPEAN JOURNAL OF HEART FAILURE 2016 18: 28-28
6 Zheng X, Botusan IR, Narayanan S, Xu C, Sole MD, Grunler J, Forsberg E, Sunkari VG, Brismar K, Catrina SB. HIF-1 attenuates oxidative stress and ameliorates renal function in diabetes. DIABETOLOGIA 2016 59: S496-S497
7 Xu C, Bentinger M, Savu O, Moshfeg A, Sunkari VG, Dallner G, Swiezewska E, Catrina SB, Brismar K, Tekle M. m Epoxidized alpha-tocotrienol enhances wound healing in the db/db mouse model of diabetes and stimulates in vitro angiogenesis and cell migration. DIABETOLOGIA 2016 59: S468-S468
8 Levitsky A, Saevarsdottir S, Brismar K, Hambardzumyan K, Lourdudoss C, van Vollenhoven R. Obesity is associated with worse clinical outcomes yet limited radiographic progression in early rheumatoid arthritis. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 2016 45: 6-6
9 Levitsky A, Saevarsdottir S, Brismar K, Hambardzumyan K, Lourdudoss C, van Vollenhoven RF. OBESITY IS ASSOCIATED WITH WORSE CLINICAL OUTCOMES YET LIMITED RADIOGRAPHIC PROGRESSION IN EARLY RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES 2016 75: 448-448
10 Levitsky A, Brismar K, Saevarsdottir S, Hambardzumyan K, Andersson A, van Vollenhoven RF. Adipokines and Insulin-like Growth Factor 1 As Predictors of Clinical and Radiographic Outcomes in Early Rheumatoid Arthritis. ARTHRITIS & RHEUMATOLOGY 2015 67:
11 Yang JN, Zheng X, Tratsiakovich Y, Kiss A, Catarina S, Brismar K, Pernow J. Red blood cells impair post-ischemic cardiac function via arginase-dependent regulation of nitric oxide synthase and reactive oxygen species in type 2 diabetes. EUROPEAN HEART JOURNAL 2015 36: 1208-1208
12 Hardy E, Brismar K, Davies M, Han J, Wolffenbuttel BHR. The effect of added exenatide twice daily or bolus insulin on insulin glargine and total insulin dose with improvedHbA(1c): subgroup analysis of the 4B study. DIABETOLOGIA 2015 58: S372-S372
13 Wolffenbuttel BH, Davies MJ, Brismar K, Han J, Hardy E. The Effect of Initial Glargine (IG) Dose on Response to Added Exenatide Twice Daily (BID) or Bolus Insulin: Subgroup Analysis of the 4B Study. DIABETES 2015 64: A290-A290
14 Brismar K, Ohrvik J. Two-year clinical study of a mHealth remote diabetes care system: interim results. DIABETOLOGIA 2015 58: S447-S447
15 Ansurudeen I, Daraio T, Kolonelou C, Bark C, Brismar K, Valladolid-Acebes I. Western diet intervention modulates regulation of IGFBP-1 protein in C57/B16 mice. DIABETOLOGIA 2015 58: S293-S294
16 Pinnick KE, Brismar K, Karpe F. Android and gynoid fat are independently associated with hepatic and whole-body insulin resistance in non-diabetic males from the Oxford Biobank. DIABETOLOGIA 2014 57: S248-S249
17 Abu Seman N, Mohamud WW, Ostensson C, Brismar K, Gu HF. DNA hyper-methylation of the zink transport (SLC30A8) gene is associated with type 2 diabetes in a Malay population. DIABETOLOGIA 2014 57: S153-S153
18 Lyssenko V, Moller C, Storm P, Poon W, Vikman P, Groop L, Rossing P, Eliasson M, Eliasson B, Brismar K, Nilsson PM. How to survive type 1 diabetes - the prolong study. DIABETOLOGIA 2014 57: S146-S146
19 Hilding A, Almgren M, Atkinson RL, He J, Brismar K, Schalling M, Ostenson CG, Lavebratt C. Human adenovirus-36 is uncommon in type 2 diabetes and is associated with increased insulin sensitivity in adults in Sweden. DIABETOLOGIA 2014 57: S301-S302
20 Valladolid-Acebes I, Daraio T, Brismar K, Ogren SO, Hokfelt T, Bark IC. SNAP-25b-deficiency increases the vulnerability to diabesity and mood disorders. ACTA PHYSIOLOGICA 2014 211: 69-69
21 Zheng X, Sunkari VG, Botusan IR, Grunler J, Catrina AI, Radtke F, Brismar K, Catrina SB. Wound healing rate is impaired by a glucose-induced overactive Delta4-Notch1 loop. DIABETOLOGIA 2014 57: S111-S112
22 Catrina SB, Sunkari V, Botusan I, Grunler J, Catrina A, Radtke F, Zheng X, Brismar K. Activated Notch1 signalling has repressive effects on wound healing in diabetes. DIABETOLOGIA 2013 56: S528-S528
23 Arnetz L, Ekberg NR, Brismar K, Alvarsson M. Gender differences in the HPA axis are abolished in type 2 diabetes. DIABETOLOGIA 2013 56: S289-S289
24 Gu T, Gu HF, Hilding A, Sjoholm LK, Karvestedt L, Ostenson CG, Ekstrom TJ, Brismar K. Implication of insulin-like growth factor binding protein 1 DNA methylation and protein variation for type 2 diabetes. DIABETOLOGIA 2013 56: S148-S149
25 Sunkari VG, Botusan IR, Grunsler J, Catrina AI, Zheng XW, Brismar K, Catrina SB. Notch-1 Signaling Is Activated in Diabetes and Contributes to Defective Wound Healing. DIABETES 2013 62: A619-A620
26 Hage C, Brismar K, Lundman P, Mellbin L, Ryden L. The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations. EUROPEAN HEART JOURNAL 2013 34: 793-793
27 Catrina SB, Sunkari VG, Botusan IR, Zheng X, Grunler J, Brismar K. Notch signalling is activated in diabetes and contributes to defective wound healing. DIABETOLOGIA 2012 55: S493-S493
28 Botusan IR, Sunkari VG, Grunler J, Svensson J, Jansson JO, Ohlsson C, Brismar K, Catrina SB. Wound healing rate is not impaired in mice with deficiency of liver-derived insulin-like growth factor-I (IGF-I). DIABETOLOGIA 2012 55: S492-S493
29 Sunkari VG, Botusan I, Lindberg S, Grunler J, Zheng X, Brismar K, Catrina SB. Blocking notch pathway improves wound healing in diabetic mice. DIABETOLOGIA 2011 54: S472-S472
30 Gu T, Gu HF, Horova E, Mollsten A, Falhammar H, Prazny M, Brismar K. Evaluation of the genetic effects of IGF2BP2 in the development of diabetic nephropathy. DIABETOLOGIA 2011 54: S121-S121
31 Kjellstrom B, Venskutonyte L, Brismar K, Ohrvik J, Ryden L. Health-related quality of life predicts survival in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI2 trial. DIABETOLOGIA 2011 54: S9-S9
32 Jang KLL, Forsberg EAD, Brismar K, Furukawa LNS, Heimann JC. High brown adipose tissue thermogenic parameters in adult female of dams fed low salt diet during pregnancy. FASEB JOURNAL 2011 25:
33 Rafnsson A, Bohm F, Settergren M, Gonon A, Brismar K, Pernow J. Improved peripheral endothelial function by the endothelin receptor antagonist bosentan in patients with type 2 diabetes mellitus and microvascular complications. EUROPEAN HEART JOURNAL 2011 32: 514-514
34 Venskutonyte L, Brismar K, Ohrvik J, Ryden L, Kjellstrom B. Patient reported quality of life predicts long-term outcome in patients with type 2 diabetes and myocardial infarction. A report from the DIGAMI 2 trial. EUROPEAN HEART JOURNAL 2011 32: 541-541
35 Venskutonyte L, Brismar K, Ohrvik J, Ryden T, Ryden L, Kjellstrom B. The impact of glucose lowering agents on treatment satisfaction and psychological well-being in patients with type 2 diabetes. DIABETOLOGIA 2011 54: S389-S389
36 Vasan SK, Gu HF, Brismar K. Variants in IGF-I and IGFBP-1 and their effects on circulating IGF-I and IGFBP-1 levels in type 1 diabetes. DIABETOLOGIA 2011 54: S150-S150
37 Spectre G, Arnetz L, Stalesen R, Daleskog M, Li NL, Brismar K, Ostenson CG, Hjemdahl P. Better Platelet Inhibition in Whole Blood is Achieved by Twice Daily Dosing of Aspirin in Patients With Type 2 Diabetes Mellitus.. CIRCULATION 2010 122:21
38 Grunler J, Dallner G, Brismar K, Brauner A, Brauner H. CoQ10 affects peripheral natural killer cells in patients with type 1 diabetes mellitus. DIABETOLOGIA 2010 53: S188-S188
39 Vasan SK, Samuel P, Antonisamy B, Thomas N, Neville MJ, Karpe F, Gu HF, Brismar K. Evaluation of the phenotypic effects of common FTO and MC4R genetic polymorphisms in a general population from South India. DIABETOLOGIA 2010 53: S125-S125
40 Arnetz LFJ, Ekberg NR, Brismar K, Alvarsson M. Gender differences in reactivity of the hypothalamic-pituitary-adrenal (HPA) axis are abolished in type 2 diabetes mellitus. ENDOCRINE JOURNAL 2010 57: S389-S389
41 Ekberg NR, Dorkhan M, Arnetz LFJ, Brismar K. Increased levels of cortisol and IGF-I after treatment with pioglitazone in patients with diabetes mellitus type 2. ENDOCRINE JOURNAL 2010 57: S393-S393
42 Gu T, Karvestedt L, Brismar K, Gu HF. Relationship between adiponectin and insulin-like growth factor-binding protein 1 and their combined effects in type 2 diabetes. DIABETOLOGIA 2010 53: S130-S130
43 Gustavsson C, Yassin K, Wahlstrom E, Cheung L, Lindberg J, Brismar K, Ostensson CG, Norstedt G, Tollet-Egnell P. Sex-Different Hepatic Glycogen Content and Glucose Output in Rats.. ENDOCRINE REVIEWS 2010 31:3
44 Sunkari VG, Grunler J, Lindberg S, Botusan IR, Savu O, Steffensen KR, Brismar K, Catrina SB. Wound healing is selectively modulated by estrogen receptors in diabetes. DIABETOLOGIA 2010 53:
45 Catrina SB, Mellbin LG, Morgenthaler NG, Botusan IR, Ryden L, Ohrvik J, Brismar K. Copeptin predicts and explains the association between IGFBP-1 and cardiovascular events in patients with type 2 diabetes and myocardial infarction. DIABETOLOGIA 2009 52: S522-S522
46 Mellbin LG, Brismar K, Ryden L, Morgenthaler NG, Ohrvik J, Botusan IB, Catrina SB. Copeptin predicts and explains the association between IGFBP-1 and cardiovascular events in patients with type 2 diabetes and myocardial infarction. EUROPEAN HEART JOURNAL 2009 30: 480-480
47 Sunkari VG, Grunler J, Lindberg S, Savu O, Botusan I, Brismar K, Steffensen KR, Catrina SB. Estrogen receptor beta modulates wound healing in diabetes. DIABETOLOGIA 2009 52: S443-S443
48 Gu HF, Efendic S, Brismar K. Genetic effects of MCF2L2 Leu359Ile polymorphism on diabetic nephropathy. DIABETOLOGIA 2009 52: S112-S112
49 Hilding A, Brismar K, Frystyk J, Flyvbjerg A, Ostenson CG. Low serum levels of insulin-like growth factor binding protein-2 predict type 2 diabetes. DIABETOLOGIA 2009 52: S331-S331
50 Wang J, Brismar K, Roy J, Razuvaev A, Hedin U. Role of Chymase in the Regulation of the Insulin-like Growth Factor System in Human Carotid Atherosclerosis. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 2009 29:7 E43-E43
51 Bjorklund A, Ma Z, Brismar K, Grill V. Diazoxide protects against hypoxia-induced beta cell damage. DIABETOLOGIA 2008 51: S225-S225
52 Sierra-Johnson J, Fisher RM, Romero-Corral A, Somers VK, Lopez-Jimenez F, Malarstig A, Hamsten A, Brismar K, Hellenius ML. IGF-I/IGF-binding protein 3 ratio: a mechanistic insight into cardionactabolic risk. DIABETOLOGIA 2008 51: S170-S171
53 Petersson U, Ostgren C, Brudin L, Brismar K, Nilsson PM. Low levels of insulin-like growth factor binding protein-1 is associated with development of type 2 diabetes: a prospective observational study. DIABETOLOGIA 2008 51: S27-S28
54 Berggren PO, Brismar K. Professor Rolf Luft, 1914-2007. DIABETOLOGIA 2008 51:5 697-9
55 Jonasson JM, Ye W, Sparen P, Apelqvist J, Nyren O, Brismar K. Risk of non-trauma lower extremity amputation in patients with type 1 diabetes - a population-based cohort study in Sweden. DIABETOLOGIA 2008 51: S179-S179
56 Catrina SB, Botusan I, Sunkari VG, Savu O, Catrina A, Grunler J, Lindberg S, Pereira T, Poellinger L, Brismar K. Stabilisation of HIF-1 alpha is sufficient to reverse the negative effect of hyperglycaemia on HIF function and to markedly improve wound healing in diabetic mice. DIABETOLOGIA 2008 51: S510-S510
57 Savu O, Nikosjkov A, Sunkari V, Botusan I, Grunler J, Brismar K, Catrina SB. Stability of mitochondrial DNA against reactive oxigen species generated in diabetes. DIABETOLOGIA 2008 51: S305-S305
58 Engvall I, Elkan A, Tengstrand B, Cederholm T, Brismar K, Hafstrom I. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability and low bioactive insulin-like growth factor. ANNALS OF THE RHEUMATIC DISEASES 2007 66: 350-350
59 Rakow A, Kistner A, Brismar K, Norman M, Vanpee M. Elevated HBA1c and hyperglycemic response to oral glucose tolerance test in school age children born preterm. EARLY HUMAN DEVELOPMENT 2007 83: S107-S108
60 Zhang D, Ma J, Brismar K, Efendic S, Gu HF. Evaluation of the association between adiponectin promoter polymorphisms and nephropathy in type I diabetes. DIABETOLOGIA 2007 50: S158-S158
61 Catrina SB, Botusan I, Sunkari V, Savu O, Grunler J, Brismar K. Impaired reaction to hypoxia as a mechanism for development of diabetic foot ulcers. DIABETOLOGIA 2007 50: S463-S463
62 Berggren PO, Brismar K. Rolf Luft (1914-2007) - Obituary. CELL METABOLISM 2007 6:3 162-163
63 Petersson U, Ostgren CJ, Brudin L, Brismar K, Nilsson P. Association between elevated blood pressure and surrogate markers for insulin resistance in a defined population. The Soderakra cardiovascular risk factor study. JOURNAL OF HYPERTENSION 2006 24: S12-S12
64 Ma J, Mollsten A, Falhammar H, Brismar K, Dahlquist G, Efendic S, Gu HF. Evidence for association of the NPY Leu7Pro polymorphism with type I diabetes and diabetic nephropathy in Swedish Caucasians. DIABETOLOGIA 2006 49: 626-626
65 Wallander M, Malmberg K, Norhammar A, Ohrvik J, Ryden L, Brismar K, DIGAMI 2 Study Grp. Insulin-like growth factor binding protein-1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes. A report from the DIGAMI 2 trial. DIABETOLOGIA 2006 49: 31-32
66 Wallander M, Brismar K, Malmberg K, Norhammar A, Ohrvik J, Ryden L, DIGAMI 2 Study Grp. Insulin-like growth factor binding protein-1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes. A report from the DIGAMI 2 trial. EUROPEAN HEART JOURNAL 2006 27: 839-839
67 Forsum E, Brismar K, Lewitt M, Lof M, Olausson H, Sohlstrom A. Body composition and the insulin-like growth factor system in relation to infant birthweight a study in healthy women during pregnancy. PEDIATRIC RESEARCH 2005 58:5 1117-1117
68 Settergren M, Pernow J, Jorneskog G, Brismar K, Kalani M. Endothelin-a receptor blockade improves nutritive skin capillary circulation in patients with type 2 diabetes and microalbuminuria. CIRCULATION 2005 112:17 U185-U185
69 Ma J, Mollsten A, Falhammar H, Brismar K, Dahlquist G, Efendic S, Gu HF. Genetic variation of the adiponectin (APM1) gene is associated with type 1 diabetes in Swedish Caucasians. DIABETES 2005 54: S164-S164
70 Mollsten A, Marklund SL, Svensson M, Brismar K, Dahlquist G. Increased risk for diabetic nephropathy in smokers carrying a polymorphism in the manganese superoxide dismutase gene. DIABETOLOGIA 2005 48: A369-A369
71 Wallander M, Ryden L, Brismar K, Norhammar A. Insulin-like growth factor-1 in patients with acute myocardial infarction but without previously known type 2 diabetes - report from the GAMI-trial. DIABETOLOGIA 2005 48: A396-A396
72 Mollsten A, Svensson M, Kockum I, Rudberg S, Brismar K, Dahlquist G. Increased risk for diabetic nephropathy in smoking patients carrying a polymorphism in the endothelial cell nitric oxide synthase gene. DIABETOLOGIA 2004 47: A48-A48
73 Brismar K, Alvarsson M, Efendic S. Low dose ACTH stimulation of cortisol secretion inhibits insulin secretion in healthy males: a possible mechanism for stress-induced glucose intolerance through inhibition of insulin secretion. DIABETOLOGIA 2004 47: A165-A165
74 Gu HF, Efendic S, Nordman S, Ostenson CG, Brismar K, Brookes AJ, Prince JA. Quantitative trait loci near the insulin-degrading enzyme gene (IDE) contribute to variation in plasma insulin levels. DIABETOLOGIA 2004 47: A137-A137
75 Olausson H, Lewitt MS, Brismar K, Sohlstrom A. Enhanced responsiveness of the insulin-like growth factor system in adult rat offspring from food restricted dams. PEDIATRIC RESEARCH 2003 53:6 39A-39A
76 Jorneskog G, Kuhl J, Kalani M, Efendic S, Ostensson CG, Brismar K. Forearm skin microvascular reactivity, IGF-1, and IGFBP-1 in healthy subjects with and without heredity for Type 2 diabetes.. DIABETOLOGIA 2003 46: A415-A415
77 Mollsten A, Kockum I, Rudberg S, Svensson M, Ugarph A, Brismar K, Eriksson JW, Dahlquist G. The plasminogen activator inhibitor-1 and the angiotensin II Type 1 receptor genes and their association with diabetic nephropathy among smokers. DIABETOLOGIA 2003 46: A335-A335
78 Grunler J, Sjoberg M, Forsman U, Khan A, Brismar K, Sindelar P. Altered lipid metabolism in liver from spontanously diabetic Goto-Kakizaki rat.. DIABETOLOGIA 2002 45: A186-A186
79 Rajamand N, Ungerstedt U, Brismar K. Glucose/lactate ratio during OGTT a measure of local insulin resistance. DIABETOLOGIA 2002 45: A183-A183
80 Jorneskog G, Brismar K, Alvarsson M, Kuhl J, Ostensson C, Bavenholm P, Katz A, Wahren J, Efendic S. Impaired microcirculatory responses to acetylcholine and sodium nitroprusside in healthy subjects with heredity for diabetes.. DIABETOLOGIA 2002 45: A383-A383
81 Zachrisson R, Brismar K. Leptin, cortisone and testosterone levels are puberty dependent both in healthy and diabeteic boys. Only leptin is impaired in diabetes. DIABETES 2002 51: A612-A613
82 Kalani M, Brismar K, Apelqvist J, Eliasson B, Eriksson J, Fagrell B, Jorneskog G. Low molecular weight heparin (Fragmin (R)) improves healing of chronic foot ulcers in patients with diabetes and peripheral arterial occlusive disease. DIABETES 2002 51: A158-A158
83 Lindgren BF, Brismar K, Ostenson CG, Jacobsson H, Jacobson SH. Decrease in age adjusted IGF-I and kidney volume decrease at eight year followup of type 1 diabetics. DIABETOLOGIA 2001 44: A34-A34
84 Hemmingsson P, Brismar K. Neuroischemic foot ulcers have a 4-fold increased healing time compare to neuropatic foot ulcers in diabetes.. DIABETOLOGIA 2001 44: A283-A283
85 Ugarph A, Mohan S, Brismar K. Osteopenia in diabetes mellitus: Correlations to IGF-1, IGFBP-1, IGFBP-3, IGFBP-4 and IGFBP-5.. DIABETOLOGIA 2001 44: A223-A223
86 Lewitt M, Berggren PO, Brismar K. Regulation of insulin-like growth factor-binding protein-1 secretion in the glucose-sensitive rat pancreatic beta cell line INS-1. DIABETOLOGIA 2001 44: A119-A119
87 Huss F, Wajngot A, Ostensson CG, Brismar K. C-peptide, IGFBP-1, IGF-1 and metabolic control predict development of microvascular complications in type 1 diabetes.. DIABETOLOGIA 2000 43: A269-A269
88 Brismar K, Kanungo A, Samal KC, Tripathy BB, Sanjeevi CB. IGF-I and IGFBP-1 in Indian diabetic populations: Type 1, type 2 and malnutritional diabetes.. DIABETOLOGIA 2000 43: A177-A177
89 Kistner A, Jacobsson S, Celsi G, Vanpee M, Brismar K. Impaired IGFBP-1 levels in normal weight women born small for gestational age suggest insulin resistance.. DIABETOLOGIA 2000 43: A88-A88
90 Nygren J, Thorell A, Ljungqvist O, Brismar K, Bang P. Changes in IGF-I, IGFBP-1 and IGFBP-3 proteolysis in response to acute exercise and insulin infusion. FASEB JOURNAL 1999 13:4 A80-A80
91 Heneen WK, Jorgensen RB, Brismar K, Chen BY, Cheng BF. Characterization of the C genome of Brassica. CYTOGENETICS AND CELL GENETICS 1998 81:2 143-143
92 Zachrisson I, Brismar K, Dahlquist G, Wallensteen M. Is IGFBP-1 of importance to the blood-glucose regulation in pubertal diabetic boys?. DIABETOLOGIA 1998 41: A177-A177
93 Kalani M, Brismar K, Fagrell B, Ostergren J, Jorneskog G. Transcutaneous oxygen tension and toe pressure as impairment of cerebral blood flow in patients with predictors for outcome of diabetic foot ulcers. JOURNAL OF VASCULAR RESEARCH 1998 35: 25-25
94 Kalani M, Brismar K, Fagrell B, Ostergren J, Jorneskog G. Transcutaneous oxygen tension and toe pressure as predictors for outcome of diabetic foot ulcers. JOURNAL OF VASCULAR RESEARCH 1998 35:4 296-296
95 Ugarph A, Brismar K, Fagrell B, Jorneskog G. Can acute indirect cooling be used to estimate peripheral autonomic neuropathy?. DIABETOLOGIA 1997 40: 2218-2218
96 Hehenberger K, Heilborn J, Brismar K, Hansson A. Increased lactate production in chronic diabetic wound fibroblasts showing decreased cellular proliferation. DIABETOLOGIA 1997 40: 1833-1833
97 Sparre K, Arvered B, Matero M, Jorneskog G, Brismar K. More than half of the diabetes population has increased risk to develop chronic foot ulcers.. DIABETOLOGIA 1997 40: 1871-1871
98 Brismar K, Sparre K. The lipstick test, an easy way to study local pressure on the diabetic foot.. DIABETOLOGIA 1997 40: 1902-1902
99 Kalani M, Brismar K, Fagrell B, Ostergren J, Jorneskog G. Transcutaneous oxygen tension and toe pressure as predictors for outcome of diabetic foot ulcers. DIABETOLOGIA 1997 40: 1898-1898
100 Djavani K, Fagrell B, Brismar K, Jorneskog G. Transcutaneous oxygen tension - Reproducibility in diabetic patients with peripheral arterial occlusive disease. DIABETOLOGIA 1997 40: 1918-1918
101 Jorneskog G, Egberg N, Fagrell B, Fatah K, Hessel B, Johnsson H, Brismar K, Blomback M. Altered properties of fibrin gel structure in patients with IDDM. DIABETOLOGIA 1996 39: 905-905
102 Lindgren BF, Jacobson SH, Brismar K. IGFBP-1 during insulin infusion to type 2 diabetes patients with renal failure.. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 1996 7:9 A0577-A0577
103 JORNESKOG G, FAGRELL B, FATAH K, HESSEL B, JOHNSSON H, BRISMAR K, BLOMBACK M. ABNORMAL FIBRIN-GEL FORMATION, AND A DECREASED SKIN CAPILLARY CIRCULATION IN THE FEET OF DIABETIC-PATIENTS. DIABETES 1995 44: A218-A218
104 CLAUSON P, BRISMAR K, GRILL V. INSULIN-LIKE GROWTH-FACTOR-I AND IGF-BINDING PROTEIN-1 IN A REPRESENTATIVE NIDDM POPULATION. DIABETOLOGIA 1995 38: A132-A132
105 BRISMAR K, GUTNIAK M, EFENDIC S. PARADOXICAL IGFBP-1 RESPONSE TO MEAL-RELATED HYPERINSULINEMIA IN TYPE-2 DIABETES. DIABETOLOGIA 1995 38: A152-A152